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Magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE)
are increasingly under investigation to explore their potential role in establishing
effective evaluation methods for the procedure of tissue regeneration carried out in vitro,
in vivo, and in disease diagnosis. To this end, there is a continuous pursuit of novel tools
both in vitro and in vivo. For instance, there is a great need for the development and
evaluation of an MR-compatible incubation system that enables simultaneous monitoring
and culturing of cell and tissue constructs using MRI techniques. Such an imagingcompatible incubation system eliminates exposing the culture to the risks of temperature
shock, sample contamination, and handling/stress during evaluation tests. Samples,
therefore, are not wasted, and can be implanted in animal models for following in vivo
experiments. While in vitro tissue engineering studies allow for extraction of useful
information, the experimental conditions cannot be truly replicated in the in vivo
environment. Animal models, therefore, are critical to assess and characterize the
regeneration of the engineered tissues. Furthermore, continuous observation of
regenerating tissues using imaging modalities can lead to a decreased number of animals,
where each animal acts as its own control.

In an effort to develop a device to promote the role of MRI in tissue engineering,
including extraction of leading biomarkers for in vitro studies, the e-incubator system
was developed, which is an autonomous MRI-compatible incubation system. MRI was
also applied in vivo on mouse models to show the potential of different MRI contrast
mechanisms in characterizing tissue-engineered bone and cartilage. The engineered
constructs were also imaged in vivo using MRE to characterize their stiffness changes.
Furthermore, the role of MRE in diagnosis of nonalcoholic fatty liver disease (NAFLD)
was investigated by monitoring the variations of liver stiffness followed by the analysis
of changes in gene expression of fibrosis-specific genes in a mouse model. Altogether,
this dissertation work showed the potential of MRI technologies in promoting tissue
engineering and disease diagnosis through introducing the e-incubator system, providing
noninvasive in vivo imaging markers for bone and cartilage regeneration, and describing
MRE as an effective noninvasive method for early detection of NAFLD.
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CHAPTER 1
DISSERTATION OVERVIEW
Motivation and Objectives
Researchers have looked into the applications of imaging techniques that
incorporate tomographic data to estimate the state of different layers inside a tissue
culture. MRI scanning is one of the tomographic methodologies observing the growth
and metabolic functions of cultured cells and constructs [1-3]. It can be utilized to
determine the distribution of the cells inoculated in tissue-like constructs, global density,
flow dynamics, and quality control in cell distribution [4]. MRI also provides great image
quality, high spatial resolution, varied contrast-weighting, 3D-multiplanar capability, and
is a noninvasive technique with non-ionizing radiation [5-7]. Furthermore, recent
developments in MRI including high field MRI, more-sensitive RF coils and gradients,
sophisticated pulse sequences, and innovative techniques open a horizon to the
applications of MRI in disease diagnosis. MRI, in addition to determining morphologic
and biological information, demonstrates the ability to assess mechanical properties of
tissues. One recently developed technique for the measurement of shear stiffness via MRI
is through a technique termed magnetic resonance elastography (MRE). Introduced by
Muthupillai et al. in 1995, MRE is a phase contrast technique that obtains information
about the stiffness of tissue by assessing the propagation of mechanical waves through
the tissue with a special technique including: 1) generating shear waves in the tissue, 2)
acquiring MR images depicting the propagation of the induced shear waves 3) processing
the images of the shear waves to generate quantitative maps of tissue stiffness [8]. This
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noninvasive technique received a great deal of attention because of higher signal-tonoise-ratio (SNR), resolution and penetration depth compared with other elastography
techniques like ultrasound elastography (UE), which allows volumetric mechanical
imaging. Over the past two decades, MRE has been demonstrated in preliminary human
studies as a diagnostic method for abnormalities in the breast, liver, kidney, prostate,
brain, blood vessels, heart, and skeletal muscle. Also, MRE is currently used clinically
for assessment of chronic liver diseases [8-11].
There is a great need for the development and evaluation of incubation systems
that closely simulate in vivo conditions and enable observation of cell and tissue
constructs using medical imaging technologies [12-15]. As compared to conventional
tissue culture systems, an autonomous in vitro culture imaging platform allows
monitoring and recording of the culture environment continuously. Such in vitro
platforms are expected to play a fundamental role in studying potential strategies for the
treatment of various diseases in humans, such as cancer [16, 17], and those associated
with bone [18], cartilage [19], and heart [20] disorders. These impose more than $1200
billion per year to the US healthcare system [21, 22]. In addition to the ex vivo
investigation of the pathophysiology of diseases, such platforms also have potential
applications in developments in regenerative medicine [23, 24], in drug delivery studies
[25, 26], and in basic biological research [27]. There are a limited number of tools to
noninvasively extract information concerning the cultured constructs without causing
destructive changes to its structure. Imaging modalities are considered to be among the
best validation methods. There is acceptance that modern medicine increasingly depends
on imaging modalities such as MRI, computed tomography (CT), and positron emission
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tomography (PET), as they can also be applied to tissue engineering studies (e.g. in tissue
characterization to distinguish the changes in the cellular features of tissue constructs and
efficiency improvement of the cell culture and its subsequent implantation) [28] and
regenerative medicine (e.g. observing the changes in transplanted stem cells in animal
models and in clinical trials) [29, 30]. Some of the known features which can be
characterized by medical imaging modalities are anatomical [31], mechanical (elasticity
and viscoelasticity) [32, 33], NMR (relaxation times, magnetization transfer, and
chemical shift) [2, 34], and biological (apparent diffusion coefficient) [35].
Within this area, it is very important that the repeated imaging of a tissue
construct is carried out in a noninvasive manner without harming the developing tissue.
Most current systems do not provide a completely noninvasive way to characterize the
culture; therefore, the samples are under risk of exposure to contamination, temperature
shock, or handling difficulties from the incubation platform to the point where they are
under assessment [2, 33, 36]. This highlights the need for an autonomous incubation
system which could function in tandem with an imaging machine and could allow us to
repeatedly visualize the variations in the structure and characteristics of the culture.
Therefore, one objective of this dissertation work was to design a novel smallscale, portable, autonomous system, known as the e-incubator, which would enable realtime visualization of cultured tissue constructs or biological compounds in miniature
sizes for different geometries and in a closed controlled environment. The design follows
the need for a system with real-time tomographic imaging capability, which is enabled by
integrating the platform with a high-field MRI system. All applied parts were designed
and adapted to facilitate MRI imaging and to reduce MR signal loss.
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TEB analysis in vivo relies heavily on tissue histological and end-point
evaluations that require the sacrifice of animals at specific time points [37-40].
Unfortunately, due to differences in animal responses to implanted tissues, these
conventional analytical methods to evaluate TEB can introduce data inconsistencies or
scattering. Also and importantly, the current methods increase the number of animals
needed to provide an acceptable statistical power for hypothesis testing. However,
through the continuous analysis of regenerating tissue, noninvasive medical imaging can
lead to decreased numbers of animals, where each animal acts as its own control [37, 41,
42]. Therefore, a second objective of this dissertation work was to test the feasibility of
multi-modal imaging techniques including MRI and near-infrared (NIR) optical imaging
to visualize and quantify TEB. In a six-month feasibility study, TEB was implanted in a
critical-sized calvarial defect mouse model. Osteogenesis of the TEB was monitored,
through signal variation, using MRI and NIR. Histological endpoint measurements and
computed tomography (CT) were used to confirm imaging findings. Taken together,
results of this part of my research demonstrate the potential of multi-modal imaging to
visualize and quantify TEB, which implies noninvasive techniques for assessment of
regenerative medicine strategies.
Although there are several studies that evaluate the in vivo growth of cartilage
[43-47], there is still a lack of information about effective and sensitive imaging markers
quantitated for cartilage tissue engineering. Such information is increasingly being used
to study engineered tissue growth, development, and regeneration in vitro and in vivo. A
third objective of this dissertation work is to characterize the biological and mechanical
features of three cartilage constructs (silk, gelatin, and collagen) after implantation in an
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11-week study. The results of this work will provide researchers with a noninvasive
rapid-feedback method for improving the engineered outcome. This research will enable
the design of better engineered cartilage tissue that can be translated into treatment of
tissue defects.
As a fourth objective of this dissertation, correlation of liver stiffness and fibrosisspecific genes expression in the evaluation of nonalcoholic fatty liver disease was
assessed. Two populations of mice, including one fed with a high fat diet and a control,
were under study for four weeks. MRE measurements were performed at 9.4 T to map
the liver tissue stiffness. The changes of liver genes expression between the two groups
were also assessed at week four by transcription of mRNA followed by real time
polymerase chain reaction. The outcome of this work helps to better diagnose
nonalcoholic fatty liver disease prior to the clinical onset of obesity.
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Dissertation Outline
Chapter 2

Presents a background of MRI including the history, fundamental

principles, the concept of relaxation, and pulse sequences.
Chapter 3

Provides a background of tissue engineering / regenerative medicine, stem

cells, mesenchymal stem cells, and bioreactors. An introduction to the need for imagingcompatible incubation systems is provided as well.
Chapter 4

Presents the design, validation experiments, and applications of the e-

incubator system, which is an MRI-compatible smart incubation system.
Chapter 5

Investigates applications of multi-modal imaging systems including MRI,

near infrared optical imaging, and CT for monitoring bone repair in a mouse critical-size
calvarial defect model.
Chapter 6

Evaluates the potential of MRI and MRE techniques to characterize the

biological and mechanical features of various cartilage constructs using silk, gelatin, and
collagen scaffolds after implantation in mice.
Chapter 7

Assesses nonalcoholic fatty liver disease (NAFLD) by quantification of

the liver stiffness and gene expression. MRE and real-time polymerase chain reaction are
presented as the techniques used to quantitate the liver stiffness and the liver genes
expression, respectively.
Chapter 8

Summarizes the work presented in this dissertation, discussing

conclusions and achievements. Recommendations for future work are also presented.
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CHAPTER 2
FUNDAMENTALS OF MAGNETIC RESONANCE IMAGING (MRI)
2.1 The History of Magnetic Resonance Imaging
In 1939 Rabi and his colleagues observed nuclear magnetic resonance (NMR)
under a very high vacuum [48]. In their study, a beam of hydrogen molecules was sent
through two different magnetic fields in which radio frequency (RF) [49] electromagnetic
energy was applied to the molecules. The first one was homogeneous and the second one
was inhomogeneous. This energy was absorbed by the molecular beam at a narrowlydefined frequency and experienced a slight deflection. Following that, Purcell, Torrey
and Pound at Harvard University, and Bloch, Hansen and Packard at Stanford University
continued the research and discovered the nuclear magnetic resonance (NMR) within a
few days of each other in 1945. The phenomenon of NMR in bulk materials, such as
water and paraffin wax in their liquid state, were investigated. They presented the
discovery in the same issue of Physical Review [50, 51]. Bloch and Purcell were awarded
the 1952 Nobel Prize for physics in recognition of their innovative achievements. Over
the following few years, the tight relation between the resonance frequency of a nucleus
and the state of its chemical environment was shown by Knight in 1949 [52], Dickinson
in 1950 [53], Lindstrom in 1950 [54], and Proctor and Yu in 1950 [55]. Later in 1951,
Arnold, Dharmatti, and Packard found separate resonance lines for chemically different
protons [56]. This was the onset of applications of NMR as the most used spectroscopic
method in all branches of chemistry. The NMR spectrum in organic chemistry provides
an important probe in structure identification and can be used by chemists to achieve
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perception of molecular structures. The NMR technique also has applications for the
identification of structural information of complex molecules with biological significance
such as proteins and nucleic acids. In 1971, the potential of detection of tumors in vivo by
NMR was reported by Damadian [57]. He showed tumors can be discriminated from the
normal tissue because of much longer relaxation times. In 1973, Lauterbur incorporated
the spatial information of protons for magnetic resonance imaging and successfully
developed a technique to generate the first MR image in 2D and 3D from an NMR
spectrometer using linear magnetic field gradients [58]. He employed the back-projection
method to generate 2D NMR images which had already been used in computer-assisted
tomography (CAT)-scan. Lauterbur published the first cross-sectional in vivo image of a
mouse in 1974 [59]. Concurrent to Lauterbur, Mansfield was pursuing the development
of a mathematical technique in the Department of Physics at the University of
Nottingham. Mansfield and Grannell described the application of magnetic field
gradients to achieve spatial data in NMR experiments [60]. Lauterbur and Mansfield
were awarded the 2003 Nobel Prize in Physiology or Medicine for their findings
concerning MRI. In 1975, Richard Ernst developed a way to reconstruct the 2D images
from Fourier transform of phase and frequency encoding which is the basis of current
MRI [61]. This method was reported that reconstructs an image from NMR signals more
rapidly than Lauterbur’s back-projection. Ernst was awarded the 1991 Nobel Prize in
Chemistry for his efforts in pulsed Fourier Transform NMR and MRI. The capacity of
such an imaging technique to diagnose diseases such as cancer was quickly understood.
During the past four decades, MR imaging and spectroscopy techniques have become
advanced by more developments in superconducting magnets, computers, imaging
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techniques, and reconstruction algorithms. Since then, MR imaging has drawn attractions
to the scientific and clinical community due to the wide range of applications for
noninvasive clinical studies of human anatomy and metabolism. For example the number
of operational MRI worldwide increased from 3 in 1981 to more than 25000 in 2013 [62].
MR imaging techniques carry some advantages over other tomographic imaging
techniques. MRI does not employ ionizing radiation like X-ray, CT, PET, or SPECT.
MRI can penetrate bone without attenuation in contrast to ultrasound. It provides high
resolution images of soft tissues without the use of contrast materials and allows greater
sensitivity with contrast agents [63-65]. To sum it up, MRI has become a well-known
clinical technique for detecting many pathological conditions and assessing metabolic
functions.
2.2 The fundamental principles of MRI
When a nucleus has an odd number of protons or neutrons or both it will include a
net magnetic dipole as well as a net angular momentum. In the case that the nucleus is
exposed to an external magnetic field B0 (in this dissertation, vectors will be denoted by
bold type letters), its magnetic moment precesses around the line parallel to the B0 as
shown in Figure 2-1. Let’s define the direction of the B0 along the z-axis. Quantum
mechanics indicates that the angular momentum and z-component of the magnet moment
are quantized. A spin number can be assigned to every nucleus as the multiple of a halfinteger which can be positive or negative. The magnetic dipole moment of spins can be
one of two possible states of m=½ and m=-½. Having the same levels of energy in the
absence of an external magnetic field, spins show a different energy level while exposed
to an external magnetic field. Each of the individual unpaired electrons, protons, and
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neutrons has a spin of 1/2 or -1/2. When the number of protons is odd or the total number
of protons plus neutrons for a nucleus is odd, it possesses spin. The spin of an individual
nucleus creates a magnetic field and, as a result, a magnetic moment; therefore, the
nucleus acts similar to a miniature magnet with north and south poles.

Figure 2-1 Orientation and precession of a magnetic dipole in the presence of an
external magnetic field (redrawn from figure 1.4, reference [66]). B0 aligned along
the z-axis direction. B0 and M are bold which specify that they have magnitude and
direction as a vector.
The magnetic moment of a nucleus precesses at the Larmor frequency which is
defined by the Larmor equation
(2.1)
where ω is the Larmor frequency, B0 is the external magnetic field in Tesla, and γ is the
gyromagnetic ratio. The gyromagnetic ratio is a specific number for each type of nucleus.
Table 2-1 summarizes the net spin, gyromagnetic ratio, and natural abundance for
multiple MR detectable nuclei (Only the nuclei with spin can be detected by NMR
techniques) playing an important role in many physiological processes [67]. The largest
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gyromagnetic ratio is 42.58 MHz/T and belongs to the hydrogen nucleus (1H); thus,
hydrogen produces the strongest magnetic signal per atom. In addition, it is the most
abundant nucleus in the body and is used in most imaging applications. Instead of dealing
with the magnetic moment of a single nucleus, the net magnetic moment M is used. At an
equilibrium condition the single magnetic dipoles precess at random phases; therefore, x
and y components of M are zero. In another words M is parallel to the z-axis.
Table 2-1 Net spin, gyromagnetic ratio, and natural abundance for common
biologically relevant nuclei [67].
Nuclei

Net spin
1/2

Gyromagnetic
ratio (MHz/T)
42.58

% Natural
Abundance
99.98

1

H

7

Li

3/2

16.55

92.58

13

C

1/2

10.71

1.11

15

N

1/2

4.31

0.36

O

5/2

5.77

0.04

17
19

F

1/2

40.05

100.00

23

Na

3/2

11.26

100.00

31

P

1/2

17.23

100.00

25

Mg

5/2

2.61

10.13

S

3/2

3.27

0.74

33
35

Cl

3/2

4.17

75.53

37

Cl

3/2

3.47

24.47

39

K

3/2

1.99

93.10

35

K

3/2

1.09

6.88

43

Ca

7/2

2.86

0.15

To investigate the NMR properties of a substance, a radiofrequency (RF) signal is
applied to nuclei resulting in another magnetic field named B1 perpendicular to B0;
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therefore, the distribution of 1/2 and -1/2 spins is disrupted and M is tipped into the x-y
plane. The B1 magnetic field has to oscillate in the same resonance frequency of a
nucleus to be able to tip its M; on the other hand, the Larmor frequency of 1H in a typical
magnetic field is in the radio frequency range. Thus, the B1 magnetic field used to tip the
net magnetic moment of a proton is achieved using an RF pulse. After applying the B1
field, M tips to the x-y plane and keeps on precessing at the Larmor frequency. This is
because, after applying the RF pulse, the magnetic moments of all nuclei precess
together, not in a random manner. At a specific time after removing the RF pulse, M
returns to its equilibrium direction parallel to the B0 because of entropy. This process is
called relaxation. The net magnetization vector will rotate in a plane perpendicular to the
applied B1 pulse and with an angle which is governed by the gyromagnetic ratio of the
nucleus, the amplitude of the RF pulse (|B1|), and duration of the RF pulse. Figure 2-2 is
an example of tipping the net magnetization vector by applying a 90˚ and 180˚ RF pulse.

Figure 2-2 Rotation of the net magnetization vector M in a Cartesian coordination
system rotating at Larmor frequency around z-axis (redrawn from figure 1.5,
reference [66]). (a) Spin system at equilibrium in a stationary magnetic field B0. (b)
After applying a 90 degree RF pulse the net magnetization vector tips to x-y plane.
(c) Applying a 180 degree RF pulse will result in inversion of the net magnetization
vector.
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To summarize, when our body is placed in the strong magnetic field of an MRI
system, the magnetic fields of its protons combine to configure a net magnetization
vector. This vector is in the direction of the main magnetic field which is called
longitudinal directions. The net magnetization vector starts rotating by absorption of RF
energy which depends on the energy and duration of the RF signal. Two important RF
pulses are 90˚ and 180˚ RF pulses which tip the net magnetization vector to the x-y plane
and the z direction respectively.
2.3 Relaxation
Relaxation is the process by which the net magnetization of a nucleus returns to
its equilibrium state after absorption of the RF signal. The net magnetization vector
which is aligned along the z direction is called longitudinal magnetization. When this
vector is tipped into the x-y plane, it is called transverse magnetization. T1 relaxation or
longitudinal relaxation happens when the magnetization vector grows back in the
longitudinal direction from zero to its thermal equilibrium value. T1 time is defined as the
time of the longitudinal growth of the net magnetization to 63% of its final value after
applying a 90˚ RF pulse as is described in Figure 2-3. Different tissues have different
values of T1 relaxation time; therefore, T1 time is one of the main sources of contrast in
MRI images.
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Figure 2-3 T1 relaxation time demonstration (redrawn from figures 9 and 10,
reference [68]). (a) 90˚ RF pulse applied to tip the longitudinal magnetization vector
to transverse plane. (b) The longitudinal magnetization vector becomes zero and
then grows up in the z-axis direction. (c) T1 relaxation time for a tissue is defined as
the time that the longitudinal magnetization grows back to 63% of its equilibrium
value.

Figure 2-4 (a) T1-weighted MRI image of a mouse brain acquired by a SEMS
sequence. (b) T2-weighted MRI image of a mouse brain acquired by a SEMS
sequence.
Figures 2-4a and b show T1-weighted and T2-weighted MRI images of a mouse
brain respectively. In a mouse brain, similar to a human brain, T1 time for white matter is
shorter than gray matter. Also, T1 time for gray matter is shorter than cerebrospinal fluid
(CSF). Therefore, white matter relaxes rapidly, CSF relaxes slowly, and gray matter
relaxes at an intermediate rate. T1 relaxation curves for these three tissues are denoted in
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Figure 2-5. To acquire a T1-weighted image, acquisition should take place at a time that
these curves are widely separated. In a T1-weighted image, the pixels related to white
matter are lighter, CSF is darker, and gray matter is at intermediate shades of gray.

Figure 2-5 Different brain tissues have different T1 relaxation rates (redrawn from
figure 11, reference [68]). White matter has shorter T1 time than CSF. Gray matter
has an intermediate T1 relaxation time compared with white matter and CSF.
T2 relaxation time is another source of contrast in MRI images. By applying the
90° RF pulse, the net magnetization vector tips to the transverse plane. When the 90° RF
pulse is introduced to the protons and immediately after, protons become in-phase; in
other words, they precess together. Then protons begin to dephase because of protons’
spin-spin interactions, magnetic field inhomogeneities, magnetic field susceptibility, and
chemical shift effects. The dephasing which happens due to the spin-spin effect is called
T2 relaxation. T2 characterizes the rate of dephasing for protons belonging to a specific
tissue and can be used as a characteristic of that tissue. To determine the T2 relaxation
time of a tissue, the amount of transverse magnetization (which is called MR signal) is
measured using a receiver coil.
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Figure 2-6 T2 relaxation time demonstration (redrawn from figures 12 and 14,
reference [68]). (a) 90˚ RF pulse applied to tip the longitudinal magnetization vector
to transverse plane. (b)Transverse magnetization maximizes instantly after applying
90º pulse and starts dephasing. (c) T2 relaxation time is defined as the time it takes
for the transverse magnetization to reduce to 37% of its beginning value.
The dephasing which is due to all four reasons is called T2*. Immediately after tipping the
net magnetization vector to the transverse plane, the transverse magnetization is at its
maximum; however, the transverse magnetization begins to dephase and its magnitude
decreases immediately (Figure 2-6b). T2 relaxation is defined as the time takes the
transverse magnetization to decay to 37% of its original value (Figure 2-6c). Figure 2-4b
illustrates a T2-wieghted mouse brain image. White matter has a shorter T2, CSF has a
longer T2, and gray matter dephases at an intermediate T2 time. These different T2 times
enable the imaging of tissues with different contrasts. If the MR signal is acquired at
times when the transverse magnetization curves are widely separated, the generated MRI
image is called T2-weighted image. By the T2-weighted contrast mechanism, CSF
contributes to lighter pixels, white matter contributes to darker pixels, and gray matter
contributes to intermediate gray-scale pixel values. It is good to emphasize that T1 and T2
relaxations take place simultaneously; therefore, as the transverse magnetization decays,
the longitudinal magnetization grows.
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2.4 Pulse sequences
Generally an MR pulse sequence is the timing of the events such as RF pulses,
gradient pulses, and signals formed after RF pulses during a typical MRI acquisition.
First of all, it is necessary to define two important MRI acquisition parameters: TR and
TE. TE or echo time is the time between the peak of the 90° RF pulse and the peak of the
echo formed after that RF pulse. TR or repetition time is the time that it takes for a pulse
sequence to run only one time. Recall that T1 and T2 relaxation phenomena can be
employed to achieve different contrasts in MRI images. For this purpose, specific
amounts of TR and TE are selected to change the weighting of T1 and T2 relaxations in
MRI images. In the following section, the definitions of sequences used in this
dissertation are described, provided as part of the VnmrJ software accessory (Agilent,
Santa Clara, CA) [24].
2.4.1 GEMS sequence
The protocol GEMS is a gradient echo 2D multi-slice acquisition technique. The
gems sequence allows comparatively fast acquisitions and short echo times. Using this
sequence, acquiring images with imaging time less than 10 seconds per image becomes
possible. The GEMS sequence allows imaging with short echo time, approximately 3 to 5
ms, which is necessary in imaging tissues with short T2 time, such as liver. Figure 2-7
shows the diagram for the GEMS sequence. A single RF pulse (excitation pulse) is used.
The GEMS sequence also allows a smaller flip angle and shorter TR time. Therefore the
GEMS sequence is well suited for scout scan, angiography, and contrast agent
enhancement studies. The GEMS sequence suffers from several limitations, such as
susceptibility effects, small signal-to-noise-ratio (SNR), and nonsteady-state artifact,
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which led to the design of a SEMS sequence which will be described later. The
susceptibility effect is because of the inhomogeneity of the magnetic field. Rapid
dephasing of spins during TE time in inhomogeneous areas of the magnetic field results
in signal loss and distortion in these regions (T2* effect). Therefore, by using shorter TE
time and applying shimming techniques (Shimming is used to reduce the inhomogeneity
of the magnetic field) the susceptibility effect will be alleviated. Additionally, smaller
slice thickness and smaller pixels (larger matrix size) help to reduce the susceptibility
effect. Reduced signal-to-noise-ratio (SNR) because of a smaller flip angle and short TR
is another limitation of the GEMS sequence. In addition, relatively short TR applied in
the GEMS sequence leads to a non-steady state, and as a result, the residual transverse
magnetization can generate echoes due to subsequent RF or gradient pulses.

Figure 2-7 Diagram of the GEMS sequence (redrawn from reference [69], page 91).
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2.4.2 SEMS sequence
Figure 2-8 describes the spin echo multi-slice protocol. The sequence employs a
90˚ excitation RF pulse as well as a 180˚ rewinding RF pulse. The SEMS sequence
provides high SNR, high resolution, and artifact-free images. The SEMS sequence is
applied for acquiring T1-weighted and T2-weighted images, to reduce the susceptibility
effect, and to scan with high SNR where it is needed. The long acquisition time and
ghosting artifacts are two limitations of the SEMS sequence. In the spin echo imaging to
acquire a T2-weighted image, TR should be long and in the order of seconds (3 to 4
seconds) to let the spins completely return to their equilibrium state, resulting in a long
acquisition time. In addition, in the case of acquiring a T1-weighted image with short TR
(< 2 second), the ghosting artifact is a probable effect. The ghosting artifact happens
because of the residual transverse magnetization following the RF pulses and the
gradients.

Figure 2-8 Diagram of the SEMS sequence (redrawn from reference [69], page 105).
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2.4.3 SEMSDW sequence
The SEMSDW sequence is a diffusion-weighted spin echo multiple-slice
sequence. To acquire a diffusion-weighted image two diffusion-weighting gradients are
applied, which completely cancel each other out. However, spins which move (due to
diffusion) along the direction of the applied diffusion gradients will acquire phase
changes which are not reversed. As a result, intravoxel dephasing occurs and signal is
lost. The pulse sequence is therefore sensitive to diffusion. Signal decay from diffusion
can be measured by comparing diffusion sensitive images and normal images. StejskalTanner gradients are the diffusion-weighting gradients. They might be unipolar, either
side of the 180 refocussing pulse in a spin echo pulse sequence, as Stejskal and Tanner
used. In a gradient echo pulse sequence they are bipolar - a positive and then a negative
gradient. In either case, the two lobes of the gradient will cancel out in tissue where no
movement occurs. The Stejskal-Tanner equation relates diffusion related measurements
(S) to measurements without diffusion weighting (S0) as denoted by the equation below:
(2.2)
where b is determined by the diffusion-weighting gradient waveform used and ADC is
the apparent diffusion coefficient. To generate an “apparent diffusion coefficient” map an
array of diffusion-weighted-imaging (DWI) images with different DW gradients are
acquired, and using a curve fitting algorithm, local ADC values are calculated. Diffusion
weighting is obtained by applying two gradients with identical duration delta (δ) and
amplitude (gdiff), separated by the DELTA (∆). Corresponding b-values are calculated
according to the Stejskal-Tanner equation
(

)

(2.3)
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The diffusion gradients can be applied along each of the readout, phase, and slice
directions. Acquisition of a spin echo based sequence for diffusion-weighted imaging
results in high quality, high resolution, and high SNR images. TR for acquiring the
SEMSDW sequence has to be much larger than the T1 time of a sample (TR in the order
of several seconds), meaning very long acquisition time in the order of an hour. Motion
can result in a serious ghosting artifact in diffusion weighted images. During each
SEMSDW acquisition a single line of k-space is acquired after each excitation; therefore,
motion between k-space lines which may have phase differences can destroy the MR
signal significantly.
2.4.4 MEMS sequence
MEMS sequence is a multi-echo multi slice sequence which can be used for T1
and T2 relaxation time measurements in a shorter time comparing with other sequences.
In a MEMS sequence after a 90º excitation pulse a series of 180º refocusing pulses are
applied and subsequent excitation pulses are acquired as shown in Figure 2-9. The results
will be a series of images with the same TRs but different echo times which are multiples
of the TE. TR time for the MEMS sequence has to be in the order of 3-4 seconds in order
to avoid ghosting artifact. This makes the acquisition time of a MEMS sequence
relatively long.
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Figure 2-9 Diagram of the MEMS sequence (redrawn from reference [69], page 95).
2.4.5 Magnetization Transfer
First discovered by Balaban et al., magnetization transfer (MT) is a unique
contrast mechanism and can be used to provide an alternative contrast method to obtain
completing morphologic information in addition to common contrasts such as T1 ,T2, and
proton density [70-72]. MT contrast in MRI images is described as the coupling between
the macromolecular protons (restricted pool) and the mobile or ‘liquid’ protons (water
pool). Liquid water protons have a T2 larger than 10 ms but the macromolecules and
membranes in biological tissues have a too short T2 (i.e. less than 1 ms). Due to the too
short T2 time, the NMR signal from the protons of bound water is not typically observed
in MRI. However, using an off-resonance pulse excitation to saturate protons in the
restricted pool can have a detectable effect on the NMR signal from the mobile (free)
proton pool. This causes an increase in the T1 of the free water and reduced signal from
the free water in tissues in which the magnetization transfer mechanism is prevalent. The
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resultant transverse magnetization is rapidly dephased and the longitudinal magnetization
requires some time (approximately 5 times T1) to return to equilibrium. This effect
generates a contrast which depends on the exchange rate between free and bound water.
This contrast is called magnetization transfer contrast and is a nonspecific indicator of the
structural integrity of tissues. MT has been applied in magnetic resonance angiography
(MRA) [73] and description of white matter lesions like multiple sclerosis (MS) disease
[74] and is under investigation for imaging other tissues [75]. Magnetization transfer ratio
(MTR) is a quantitative value of the MT influence on tissues. It is the degree of signal
suppression of a given tissue compared with the common PD or T1-weighted image. The
MTR can be generated by acquiring two similar images such as PD or T1-wighted, one
with and one without MT saturation. For a tissue of interest the MTR is calculated from
the two images following the equation
(2.4)
where Mo and Mt stand for the signal intensity with the saturation pulse off and on
respectively. MTR has been used in neuroradiology to highlight abnormalities in brain
structures. Magnetization Transfer Contrast (MTC) is obtained by applying a long RF
pulse (typically 6-8 ms) with a large RF power (specified as a large flip angle) at an
offset of several kHz. Figure 2-10 is a comparison between MTC, T1-weighted, and T2weighted images of a mouse brain in horizontal sections [71].
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Figure 2-10 MRI of a mouse brain in horizontal sections. (a) MTC image. (b) T1
contrast image. (c) T2 contrast image. Natt et al. showed that MTC enables
discrimination of densely packed gray matter from white matter in a mouse model
[71].
2.5 Magnetic Resonance Elastography (MRE)
Magnetic resonance elastography (MRE), first described by Muthupillai et al. in
1995, is a phase-contrast based MRI technique that uses propagating shear waves through
tissue to noninvasively characterize mechanical properties of materials such as the shear
modulus or Young’s modulus. [76]. Historically, physicians have been using palpation to
discover unusual changes in mechanical properties of tissues, which can be a sign of
abnormalities such as cancers and tumors. Although diagnosis through palpation is
constrained to the approachable areas of the body, invasiveness of other conventional
assessment techniques such as biopsy raised the need for a noninvasive elasticity imaging
technique which is capable of measuring mechanical properties [76]. In addition, imaging
techniques such as ultrasound, CT-Scan, and MRI are not able to detect small lesions
[77]. It was shown that the elasticity variation of different tissues in the body is higher
compared to the range of changes in physical properties which are the source of contrast
in conventional imaging modalities [78, 79]. Besides magnetic resonance elastography,
ultrasound based elastography (UE) introduced by Ophir et al. in 1991, is another
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noninvasive method for imaging the elasticity of biological tissues. Although UE is a
successful method and is clinically used, it is limited by the signal to noise ratio (SNR),
resolution and restricted acoustic window for transmitting ultrasonic waves [76, 80, 81].
Over the past two decades MRE has been demonstrated in preliminary human studies as a
diagnostic method for abnormalities such as tumors, especially in the breast, liver,
kidney, and prostate, and rehabilitation evaluation, and is currently clinically used for
assessment of fatty liver diseases.
The theory of MRE is proved by considering phase shift in the acquired NMR
signal as a function of dot product of the gradient vector and the position vector [76]
following the equation
∫
Let

(2.5)

be the gyromagnetic ratio related to the isochromat rotating inside the magnetic

field,

be the magnetic field gradient, and

be the spin position vector described

as
(2.6)
where

represents the beginning position and

around its mean location, and

is the displacement vector of spin

be the gyromagnetic ratio related to the isochromat

rotating inside the magnetic field. For a rectangular magnetic field gradient and a nuclear
spin displacement
(2.7)
the phase shift in the acquired NMR signal is simplified to the following equation.
(2.8)
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This equation represents that the accumulated phase shift as a result of the propagating
mechanical waves with a wave vector of k has a direct relation with dot product of the
displacement vector ( ) and the gradient vector (

), the period of the gradient pulse

(T), and the number of gradient cycles (N). θ is the phase difference between motion
encoding gradients and the mechanical excitation [76, 82].
In practice, an external vibration source is applied to the tissue of interest and the
resulting displacement within the tissue is calculated based on analysis of phase shift in
the acquired MR signal. The phase shift image is derived from subtracting two phasecontrast images acquired by toggling the polarity of motion encoding gradients (MEGs)
from positive to negative subsequently. This procedure helps to suppress the symmetric
phase-shift error and improves sensitivity to low amplitude vibrations by a factor of two.
Depending on the amplitude of the displacement applied to the tissue of interest, an
appropriate number of MEGs (bipolar rectangular gradients) are chosen to accumulate
sufficient phase shift depicting the mechanical waves i.e. a higher number of bipolar
gradients means more sensitivity [83].
The shear modulus (shear modulus () correlates transverse strain and resulting
stress in isotropic materials) can be estimated from the propagating wavelengths through
the tissue of interest. Considering

(Hz) as the frequency of mechanical vibration and

(m) as the wavelength of the propagating shear waves,

(m/s), the velocity of shear

waves, will be depicted by the equation below.
(2.9)

.
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The shear modulus

(Pa) (1Pa=1N/m2) for a simple isotropic linear-elastic

material is calculated as the product of its mass density (kg/m3) and squared velocity as
described by the following equation.
(2.10)
Measuring the shear modulus depends on applied vibration frequency; therefore,
the calculated shear modulus for a material in a specific frequency is called shear
stiffness which is also denoted by . The real and imaginary parts of the complex shear
modulus are referred to as storage modulus and loss modulus respectively. The storage
modulus represents elastic properties of a material while the loss modulus describes how
viscous it is [84]. Furthermore, to calculate the local stiffness values from the
displacement distribution, different algorithms such as solving an inverse problem have
been developed [85-87].
A typical gradient-echo based MRE pulse sequence is shown in Figure 2-11 including the
radio frequency pulse, slice-selection gradient, phase-encoding gradient, and frequencyencoding (or readout) gradient. The MEGs are shown in the frequency-encoding direction
only; however, motion occurring in any direction can be encoded into the phase of the
MR image by manipulating the axes on which the MEGs are placed. Two wave images
are typically collected with a positive and a negative MEG, and a phase-difference image
is calculated, either by subtraction or complex division, to remove all phase information
not related to the imparted motion. Besides, multiple phase offsets θ, evenly distributed
over a period of the mechanical excitations, are selected in order to acquire timedependent data and show the propagation of the wave through the tissue of interest. The
motion-encoding capability of this technique is very sensitive and can detect motion on
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the order of 100’s of nanometers [88]. The motion encoding gradients can be
implemented with many MR imaging sequences; as such we developed gradient-echo,
spin-echo, and multiple-echo spin-echo based MRE sequences and installed them on
VnmrJ 3.1 software (Agilent, Santa Clara, California).

Figure 2-11 Diagram of the gradient-echo MRE pulse sequence (redrawn from
references [69] and [8]). A negative motion encoding gradient (MEG) used for
phase-contrast imaging is shown. θ is the delay between the motion waveform and
the MEG.
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CHAPTER 3
BIOREACTORS FOR TISSUE ENGINEERING: PRINCIPLES, DESIGN AND OPERATION
3.1 Tissue Engineering/ Regenerative Medicine
Tissue engineering is a rapidly growing interdisciplinary field in medicine
combining engineering and life science to develop replacements for damaged tissues [24,
89]. The increasing need for implantation of tissues and organs is a critical situation and a
crisis for regenerative and reconstructive medicine [90, 91]. Tissue engineering employs
cells, biomaterials, and biologically active molecules in order to construct functional
tissues. Artificial tissues such as skin, fat, bone, and cartilage have been regenerated
using tissue engineering techniques; however, they are not widely used for curing human
patients yet. The terms tissue engineering and regenerative medicine are identical in most
cases. The regenerative medicine term embodies a wider field including the research on
the capability of the body to reconstruct its tissues by aid of applied biomaterials. Besides
medical applications, the regenerative medicine extends to non-therapeutic applications
such as the development of engineered tissues to work as biological or chemical sensors.
Tissue loss in the body is a widespread problem and it is challenging and costly to repair.
Many diseases or disorders can result in tissue loss which might lead to disability. For
example, trauma, infection, neoplasm, metabolic disorders, genetic and congenetic
conditions can be causes of tissue losses [92-94]. One of the frequent disorders is
orthopedic problems which sometimes cannot heal without interventional treatments. For
instance bone tissue diseases including critical-size bone defect [95], bone tumors [96],
and spinal fusion surgery [97] are a major problem for healthcare systems. However,
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treatment options for each of these diseases have some limitations and can be improved
by tissue engineering techniques generating bone tissue from cells using a structural
scaffold in vitro to implant in the defect sites [95].
Cells, biomaterials, and biomolecules play an important role in the process of
forming engineered tissues. Figure 3-1 demonstrates the structure of an intestine wall
tissue. Cells are the building blocks of tissues in the body and are held together by cellcell adhesions, extracellular matrices, or both [98]. The extracellular matrix secreted by
cells, is the assembly of extracellular molecules that deliver structural and biochemical
support to the cells around it. Besides cells, biomaterials are employed in tissue
engineering to physically or chemically enhance the organization, growth, and
differentiation of cells. Biomolecules in the form of growth factors, differentiation
factors, or as any kind of proteins are incorporated in the culture.

Figure 3-1 Basic illustration of a cross-section through part of the intestine wall
showing the assembly of cells stuck together by cell-cell adhesions, extracellular
matrices, or both [99].
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Stem cells are the most common form of cells used in tissue engineering;
however, partially differentiated cells are also applied. Cells from different origins have
been used in tissue engineering which can be from the patient’s body (autologous), from
another person (allogeneic), or from animals (xenogeneic). Obviously, tissue engineering
products do not come without risk, and given the difficulty and cost of the tissue
engineering based therapies, other approaches are also being chased. While scientists
have worked to overcome many of the challenges regarding tissue engineering, ethical
and scientific concerns such as long-term chromosomal stability, tumor formation, and
ethical standards for harvesting of ova still continue to be addressed.
3.2 Stem Cells
There is confusion in the terminology of stem cells due to the continuous
evolution of this area. Stem cells conventionally are classified as totipotent, pluripotent,
or multipotent because of their ability to differentiate into various tissues. Totipotent stem
cells are defined to have the ability to give rise to all likely cell types of an organ.
Pluripotent stem cells were known to have less capability for differentiation than
totipotent stem cells and cannot produce extraembryonic tissues or form an entire
organism. However, recent studies showed that pluripotent cells can actually give rise to
some of the extraembryonic tissues [100]. Multipotent stem cells were thought to have a
more restricted differentiation capability compared with pluripotent cells and can only
give rise to a few lineages that build a limited number of tissues. For instance, adult stem
cells found in adult tissues, as an example of multipotent stem cells, were thought to be
only capable of differentiating into cells of that specific tissue type. However, it has now
been reported that the adult stem cells can differentiate into cells of other lineages not
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from the same origin [101]. Mesenchymal stem cells (MSCs), another type of multipotent
stem cells, have been demonstrated to differentiate into a variety of non-mesodermal
tissue types such as ectodermal astrocytes [102], endodermal hepatocytes [103],
osteoblasts (bone cells) [104], chondrocytes (cartilage cells) [105], and adipocytes (fat
cells) [106]. Stem cells are also categorized based on their capability to produce a single
lineage or multiple lineages within a tissue which are called unipotent and oligopotent
respectively. Figure 3-2 summarizes the types of human stem cells including embryonic
stem cells, fetal stem cells, umbilicus stem cells, and adult stem cells.

Figure 3-2 Various types of human stem cells categorized by their origins (Bongso
and Lee [23]). The bold rout is for MSCs.
3.3 Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSCs) are a type of multipotant cells which are found
in the mesodermal (middle) cells layer in the trilaminar embryo. MSCs develop into a
connective tissue called mesenchyme which persists after birth. The history of MSCs
goes back to a series of studies in the 1960s and 1970s by Friedenstein and his colleagues
[107-110]. They showed that a minor subpopulation of bone marrow (BM) cells had the
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potential for osteogenesis and their origin was from the stromal compartment of BM.
They could distinguish these cells from the majority of hematopoietic cells due to their
fast adherence capability to tissue culture chambers [108]. The currently popular term of
mesenchymal stem cells was first used by Caplan in 1991 [111]. He described that the
generation of bone and cartilage tissues in embryos and adults involves the growth of a
small number of cells called MSCs. He suggested that MSCs provide the foundation for
self-cell repair and engineering tissues to be used in therapy. A privilege of MSCs is that
they do not evoke the same level of ethical issues as those linked to the human embryonic
stem cells [112]. Besides ethical issues, a feeder layer with a mouse origin is necessary
for isolation and expansion of the human embryonic stem cells. The presence of these
animal cells in the production process of embryonic stem cells is a large concern for
regulatory authorities [113]. Another privilege is that MSCs can be taken from a patient,
be used for engineering required tissue, and then be implanted back into the same patient
without evoking any immune response in the body. Researchers have looked into the
influences of hormones, vitamins, growth factors and cytokines in growth and
differentiation of MSCs [114]. Using MSCs in the tissue engineering field can address a
wide range of clinical applications [115, 116].
MSCs were first detached from mammalian bone marrow then they have were
found in different tissues such as periosteum, trabecular bone, adipose tissue, synovium,
skeletal muscle, deciduous teeth [117], brain, spleen, liver, kidney, lung, thymus,
pancreas [115], dermis [118], blood [119, 120], tendon and ligament. Dazzi et al.
reported that MSCs have been found in different species including humans, mice, rats,
baboons, sheep, dogs, pigs, cows, and horses [121].
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MSCs are often called bone marrow stromal cells because they are commonly
collected from the stromal section of bone marrow. It is known that mammalian bone
marrow consists of hematopoietic, endothelial and stromal cellular systems [122, 123].
Different molecular signals have been applied to stimulate differentiation of MSCs
toward a specific lineage. These signals include growth factors and cytokines such as
fibroblast growth factor (FGF), transforming growth factor-beta (TGF-β1), bone
morphogenetic protein (BMP), hormones such as dexamethasone, vitamins such as
ascorbic acid, and chemicals such as β-glycerophosphate [124, 125].
Bone tissue engineering is one of the most prevalent applications of MSCs.
Bruder et al. was the first team, in a proof-of-concept study, to report bone repair in large
animals using MSCs. They investigated the effect of cultured autologous mesenchymal
stem cells on the healing of critical-sized segmental defects in the femora of adult female
dogs for 16 weeks [126, 127]. Bone tissue repair using MSCs is now largely accepted and
a wide spectrum of research can be found in literature [128-130]. Another major
application of MSCs in tissue engineering is cartilage repair. Repair of adult cartilage
tissue has some difficulties because of the avascular nature of cartilage and the limited
potential of chondrocytes to proliferate [131]. MSCs seeded within a 3D scaffold and
treated with members of growth factors, including the transforming growth factor-β
(TGF-β), have the capability of developing into chondrocytes [132]. Figure 3-3
demonstrates the growth factors and mechanical stimulations, commonly applied on
MSCs to grow and differentiate toward cartilage and bone [133].
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Figure 3-3 Effect of growth factors and mechanical stimulations on MSCs
differentiation into chondrogenic and osteogenic lineages. High oxygen
concentration and shear stress have negative effects on MSCs renewal. Cyclic strain
and shear stress have positive effects on differentiation into chondrogenic and
osteogenic lineages respectively (redrawn from reference [133]).
3.4 Bioreactors
Bioreactors have been used in the production processes of the food,
biopharmaceutical, biochemical and tissue engineering industries over many years. A
bioreactor can be any device or system designed to provide a biologically active
environment. In our case, a bioreactor particularly refers to a device or system
manufactured to culture cells or tissues in an environment that mimics in vivo conditions
(e.g., nutrients, growth factors, and mechanical environment). These systems are being
improved with applications in tissue engineering and biochemical engineering. A
classification of various bioreactors based on their geometries is shown in Figure 3-4.
Petri dishes, flasks, and plastic bags are the simplest bioreactors, which include a static
chamber without any stirring component. Cells are placed inside cell culture media
consisting of components within serum that provides the required microenvironment and
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are accountable for growth and differentiation of MSCs. To regulate the media, gas
exchange, including oxygen and carbon dioxide, happens at the media/gas boundary. In
the following sections we will review various types of the bioreactors available in the
literature.

Figure 3-4 Classification of bioreactors based on their geometries
3.4.1 Mixed Bioreactors
3.4.1.1 Spinner flasks
The spinner-flask bioreactor consists of a cylindrical glass or plastic container and
a central stirring element, usually a magnetic stirrer shaft, and side arms. The stirring
element ensures the culture media are fairly mixed. Cultured tissues are suspended into
the media [134, 135]. Figure 3-5a shows the prototype of a spinner-flask bioreactor [134].
The rotation of stirring bar at the bottom of the flask is for promoting the mass transfer of
the nutrients. Side arms are used for the addition and removal of cells and media, and
gassing with 5% CO2 concentration air. The prototype of the spinner-flask was provided
by Freed and Vunjak-Novakovic of MIT and used to grow cartilage. The cylindrical glass
flask includes four symmetrically placed pins to hold constructs. The constructs are
separated by spacers made of silicone tubing (Figure 3-5b). Mixing is done by a magnetic
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stirrer at the bottom of the flask. In several studies spinner flasks were used for
cultivation of MSCs with osteogenic differentiation [136-139].

(a)
(b)
Figure 3-5 Prototype and model spinner-flask bioreactors [134]. (a) Prototype
bioreactor. The rotating stir bar at the bottom is used for mixing the media. (b)
Prototype construct array. Four needles are used to hold the constructs which are
attached to the cap of the flask.
3.4.1.2 Rotating-wall bioreactors
The rotating-wall bioreactor was first developed by Wolf (NASA Johnson Space
Center) and Schwarz (NASA contractor Krug Life Sciences) [140, 141] to study the
effects of microgravity on human cells on a space shuttle [142]. A rotating-wall
bioreactor includes a horizontally rotating cylinder filled with culture media as shown in
Figure 3-6a. There is no gas-liquid interface and liquid rotates inside the cylinder at the
same rotating rate as the wall. The rotation speed of the media is considered identical and
opposite of the sedimentation rate of cells or micro-carriers so that the cell suspension
can stay in a state of ‘free-fall’ (Figure 3-6b). Viscous flow around the falling particles
reduces the thickness of the boundary layer surrounding the cells inside the particles,
resulting in a shorter diffusion distance from the bulk media to the cells. Oxygenation of
the media is provided by a silicone membrane wrapped around a central cylinder. Figure
3-7 shows an advanced rotating-wall bioreactor manufactured by Synthecon Inc.
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(a)
(b)
Figure 3-6 (a) A ground-test model of the NASA Bioreactor shows the key elements,
a rotating plastic cylinder enclosing a tubular membrane that infuses growth media
and oxygen and removes wastes. (b) Cell constructs grown in a rotating bioreactor
on Earth (left) eventually become too large to stay suspended in the nutrient media.
In the microgravity of orbit, the cells stay suspended. Rotation then is needed for
gentle stirring to replenish the media around the cells [143].

Figure 3-7 Synthecon Inc. has further advanced the bioreactor technology, creating
platforms like this perfused culture system that allows the cell growth medium to be
exchanged, sampled, or modified without stopping the bioreactor’s rotation and
potentially damaging the cells [143].
3.4.1.3 Wave bioreactors
A wave bioreactor system developed by Singh et al. is shown in Figure 3-8. This
bioreactor provides a controlled wave motion for mixing the culture. It delivers higher
oxygen transfer compared with spinner flasks and has been demonstrated as an
alternative for stirred-tank bioreactors for working volumes between 1 and 100 L [144].
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Their setup includes gas-permeable bags simply placed on a rocker. By swing of the
rocker, a wave motion is generated within the gas-permeable bags. Using commercially
available polyethylene bags can be a problem for this bioreactor system due to their
cholesterol adsorption. The problem could be solved by pre-treating the bags or switching
them with inert fluorinated ethylene propylene [145]. The disposable contained bag
system has been effectively used in clinical applications; however, it can be used for
MSCs growth and differentiation as well.

Figure 3-8 Disposable wave bioreactor for cell culture designed by Singh in 1998
[144].
3.4.2 Perfusion Bioreactors
3.4.2.1 Column bioreactors
Column bioreactors are designed such that the culture media can flow uniformly
through the column govern by hydrodynamic principles [146]. Figure 3-9 represents the
column bioreactor developed by Veliky et al. in 1981 [147, 148]. The hydraulic
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resistance of the column bed and the form of the headers attached to the columns are two
important factors forming the flow distribution. Apparently, non-uniform hydraulic
permeability of the cultured scaffold results in non-uniform flow distribution. In other
words, if the scaffold porosity is uniform, the flow of media will be uniform and will
mainly depend on the hydraulic permeability of the scaffold. Figure 3-9b shows the
column bioreactor designed by Bancroft et al. [149, 150]. The scaffold is placed in a
tubular cassette held between two ‘O’ rings used for sealing purpose. This causes the
media to flow through the scaffold rather than around it. Studies show that media flow
stimulates oxygen transport [151], osteogenesis, and mineralization [149, 152-155].
Goldstein et al. and Wendt et al. in two different studies reported that osteogenic
differentiation is improved in perfusion bioreactors compared with spinner flask and
rotating-wall bioreactors [156, 157]. A challenge to the static and perfusion systems is
uniform seeding of the scaffold. Applications of oscillatory flow [157] or low pressure
[158] were investigated to overcome this problem. The perfusion bioreactors have also
been applied for cartilage tissue engineering [159-163]. Mahmoudifar, et al. used a
column bioreactor to culture chondrocytes isolated from human fetal epiphyseal cartilage
and seeded into polyglycolic acid (PGA) scaffolds to regenerate tissue-engineered
cartilage [164]. The bioreactor is composed of a 15-mm glass tube including three
separate parts assembled together with uses of a double-flanged section in the middle and
two single-flanged sections on either side. The scaffold is placed in the glass tube within
the double-flanged section after seeding and glued using to the glass walls using Selleys
Kwik Grip contact adhesive (Selleys, Padstow, Australia). After assembling three
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bioreactors via joint clips, they are connected using silicone tubing to a medium reservoir
(500 ml Schott bottle).

(a)

(b)

Figure 3-9 (a) Column bioreactor designed by Veliky et al. in 1981 [148]: 1) Column
with immobilized cells in Ca-alginate beads; 2) Air inlet; 3) Air outlet; 4) Airlift
pump; 5) Medium buffer reservoir; 6) Sampling outlet. (b) Column bioreactor
designed by Bancroft et al. [149]. Top: Flow chamber and cassette diagram; Bottom:
Flow perfusion system flow circuit diagram.
3.4.2.2 Parallel-plates
A parallel-plates bioreactor designed by Peng et al. is a radial-flow-type
bioreactor used for the growth and differentiation of parenchymal cells ex vivo [165]. The
bioreactor is composed of two main sections including a gas section and liquid-filled
bottom section. The gas section is separated from the bottom section by a membrane
which is gas-permeable but liquid-impermeable. The liquid-filled bottom section consists
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of a tissue culture plastic surface for support of anchorage-dependent cells (Figure 3-10).
Culture media flow radially within the liquid section over cells and exit into a waste
reservoir. The bioreactor has been placed into a cell production system to inoculate and
harvest the cell culture. This cell production system is composed of an incubator and a
processor. The bioreactor, a disposable cell cassette, was designed to fit into the
processor and incubator units. Dennis et al. employed the parallel-plates perfusion
bioreactor to significantly give rise to CFU-F and progenitors with osteogenic potential
from bone marrow mononuclear cells [166].

(a)

(b)

Figure 3-10 (a) Schematic representation of the microchannel parallel plate
bioreactors designed by Roy et al. [167]. The reactor has a semipermeable
membrane on the upper surface for internal oxygenation. (b) Right bottom is the
bioreactor flow schematic designed by Gemmiti et al. [168]. The bioreactor is
comprised of two media chambers, one above and one below the tissue, which
resides on a semi-permeable membrane. The upper media chamber is a rectangular.
Flow of nutrient media through the upper chamber results in a parabolic velocity
profile when fully developed. Consequently, a shear stress is developed in the
chamber that is maximal at the surface of the tissue. Left is the bioreactor assembly.
Right top is the flow circuit of the bioreactor.
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3.4.2.3 Hollow- fiber bioreactor
The clinical use of hollow-fiber devices for cell culture was introduced in 1990 by
Knazek et al. [169]. During these years, hollow-fiber bioreactors have been used for
mammalian cell culture experiments including lymphocyte expansion, gene transfer to
hematopoietic cells, generation of recombinant proteins and viruses, and hepatocyte
culture [170]. Hollow-fiber bioreactors have been applied for cartilage tissue engineering.
Fourier-transform infrared imaging spectroscopy was used to measure the distribution of
collagen, proteoglycan and glycosaminoglycan content within the hollow-fiber bioreactor
[171]. Hollow-fiber bioreactors are widely used for renal dialysis, where blood is passed
through the intracapillary side of a hollow-fiber membrane dialyzer with a low molecular
weight cut-off [172]. Hollow-fiber membranes are used in hemodialysis as artificial
kidneys to cure renal disease.

Figure 3-11 Hollow fiber bioreactor [173]. a) Circuit. b) Longitudinal and crosssectional views.
A hollow-fiber bioreactor is composed of intracapillary and extracapillary spaces.
A bundle of hollow-fibers is potted in resin and intracapillary flow is allocated to the
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hollow-fiber bundle by especially-designed headers (Figure 3-11). Hollow-fiber
bioreactors can be designed so that flow allocates equally to each hollow fiber in the
bundle [146].
The cells attached to the inside surface of hollow fibers are exposed to a uniform
shear stress because of the parabolic velocity profile of the flow inside the hollow fibers.
This shear stress is directly proportional to the intracapillary flow rate. All hollow fibers
are secured in a cylindrical chamber with inlets and outlets for flow of media around
hollow fibers. Because of the semi-permeable structure of the hollow-fiber membrane,
molecular species can permeate based on the pore size of it. High upstream pressure in
hollow-fiber bundles can push intracapillary medium out of the upstream side of the
fibers, which is then pulled into the fiber downstream. Termed Starling flow, this
secondary flow has a tendency to push cells towards the downstream end of the hollow
fibers [174]. This flow does not intervene in the function of hollow fiber dialysis devices
because of their much lower hydraulic permeability compared with macroporous
membranes [141].
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CHAPTER 4
THE e-INCUBATOR: AN MRI-COMPATIBLE AUTONOMOUS INCUBATION SYSTEM
This chapter is based on previously published work by the author [175]. Shadi F.
Othman, Karin Wartella, Vahid Khalilzad-Sharghi, and Huihui Xu. Tissue Engineering
Part C: Methods. doi:10.1089/ten.TEC.2014.0273. Copyright©2014 Mary Ann Liebert,
Inc. publishers.
4.1 Introduction
The development of instruments that enable noninvasive ex vivo testing and in
vitro imaging during tissue culture procedures holds great promise in modern medicine
[176, 177]. For example, such instruments can potentially help identify and screen novel
therapeutics in different disease models used by drug companies and academic
researchers. With the application of imaging to disease models more complete and
informative datasets can be obtained. Imaging can replace terminal sacrifice based
assays, through ex vivo noninvasive, longitudinal imaging. Specifically, these instruments
could visualize the activity of incubated brain slices, such as MR relaxometry, diffusion,
molecular content through magnetization transfer or MR spectroscopy, and stiffness
measurement using MR Elastography [178]. Also, it is possible to use diffusion-weighted
MRI [176] to study the acute temporal evolution of diffusion changes in multiple brain
slices following experimental perturbation. Another example of an expected benefit from
such instruments is in the field of tissue engineering. The concept of tissue engineering
was introduced over 25 years ago, but a limited number of products have been approved
for clinical application [179]. The tissue engineering community has been vocal in
seeking noninvasive instruments to assess and steer the development of tissue-engineered

46
constructs [180]. Thus, offering an instrument that can facilitate noninvasive visualization
capabilities using traditional medical imaging technologies is expected to expedite the
translation of tissue-engineered products to clinical settings.
Medical imaging technologies have proved their superiority in clinical settings for
the diagnosis of various diseases. These imaging technologies have the potential to play a
major role in tissue culture applications. Among such imaging technologies, magnetic
resonance imaging (MRI) is highly desirable because it does not use ionizing radiation
and is therefore well suited for longitudinal studies. However, one major problem is that a
specimen allocated to a test tube for imaging cannot be tested for a prolonged period of
time nor can it be returned to the incubator. In turn, the sample is wasted due to potential
contamination and transfer in a sub-optimal growth environment. Until this problem is
resolved, the benefits that medical imaging can provide to these diverse fields cannot be
fully realized. In this paper, we present a miniature MRI-compatible incubator, termed
the e-incubator. The e-incubator is an initial step in developing the next generation of
instruments that can enable real-time, on-board imaging for tissue specimen testing and
clinical applications. The e-incubator is a standalone unit that is controlled via a
microcontroller (MCU). The MCU acts as a central control unit to automatically sense
and regulate physiological conditions (e.g., temperature, CO2, and pH) and to perform
media exchange for cultured constructs. In the current design of the e-incubator, MRI
compatibility is pursued because MRI represents the most-sophisticated, clinically viable
technique available today. With proper adjustments, the design of the e-incubator can be
revised to incorporate other imaging modalities such as computed tomography (CT) and
optical imaging.
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Since late 1990s, perfusion-based tissue culture systems, such as hollow fiber
bioreactors (HFBRs), have been designed in parallel with improvements in highresolution MRI. While HFBRs are compatible with MRI, most of the available designs
fail to address how to maintain an optimal growth environment for tissues. Additionally,
most HFBRs can only function in a continuous perfusion mode, which requires a pause in
flow during imaging sessions. In turn, the quality of the MR images is compromised by
magnetic susceptibility artifacts due to hollow fibers [181-183]. Still, these studies
highlight the continuous pursuit of technological innovation to dynamically monitor the
development of tissue-engineered constructs. Importantly, the invention of the eincubator provides a standalone unit that eliminates the need to use unwieldy incubator
units. Our concurrent tissue culture and evaluation approach offers an innovative scheme
to study, in real time, the underlying mechanisms associated with the structural and
functional evolution of tissues while they are growing.
Given its clinical significance, we selected tissue-engineered bone as a model
system to demonstrate the feasibility of our instrument. Trauma, osteoporosis, and bone
cancer together cause over two million cases of bone injury or loss in the United States
annually [184]. Natural bone healing following injury or disease is the preferred option to
overcome osteogenic tissue loss and bone damage. However, because bone has a limited
capability to regenerate and remodel, often the surgeon will need to implant synthetic
materials or bone grafts at the site of injury. Specifically, for fractures that do not heal
naturally, approximately one million cases of bone grafts are performed annually in the
United States as treatment, resulting in an estimated annual cost of over $3 billion. Both
autologous and allogeneic bone grafts are used clinically as bone substitutes. However,
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the availability of compatible grafts is limited given that harvesting bone is painful, and
the procedure carries significant risk of infection. Therefore, tissue-engineered bone has
emerged as a promising alternative for creating functional substitutes [185]. Still, one
challenge in the clinical utility of tissue-engineered bone is the avoidance of non-specific
tissue development (i.e., ensuring stable expression of the osteogenic phenotype prior to
implantation). In particular, the clinically relevant event that murine mesenchymal stem
cells (MSCs) can transform into a malignant disease during in vivo regeneration has been
documented [186, 187].
Successful tissue engineering requires gradual assessment of developing tissues.
The different growth stages of tissue-engineered bone constructs are defined by changes
in the osteogenic phenotype (i.e., cell proliferation followed by extracellular matrix
[ECM] development and finally bone mineralization). Specific gene expression at each
stage characterizes this progression [188]. Conventional biochemical and
immunohistochemical analyses provide critical markers of osteogenic development,
including alkaline phosphatase (ALP), collagen type 1 (COLL1), osteopontin (OPN),
osteocalcin (OCN), and bone sialoprotein (BSP) [189-191]. For example, OCN is a bone
turnover marker and appears concurrently with ECM mineralization [38, 192].
Nevertheless, such immunohistochemical analyses are destructive to the tissue.
Currently, no reliable technique has been established that can measure osteogenic
phenotype expression for tissue-engineered constructs in a continuous and noninvasive
manner, similar to the proposed technique in this study. Only recently have researchers
begun to explore the potential for medical imaging techniques to monitor developing
bone tissues. In particular, MRI can visualize structural and functional changes associated
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with bone formation [1, 177, 182, 183, 193]. For example, MRI relaxometry parameters,
such as T2-relaxation time, can be correlated with ALP activity. Similarly, evaluation of
the magnetization transfer (MT) effect can reveal changes, with high specificity, in
collagen content associated with osteogenesis.
4.2 Experimental
4.2.1 Specimen preparation
Osteogenic tissue-engineered constructs were prepared using human
mesenchymal stem cells (hMSCs), isolated from donated, commercially available, fresh
adult human bone marrow (Lonza, Walkersville, MD) seeded into a biodegradable,
sterile, gelatin scaffold (Gelfoam®, Baxter Healthcare Corporation, Hayward, CA); this
scaffold was trimmed into 3.5 mm x 3.5 mm x 4 mm sections at a density of 106 cells/mL.
Second, similar constructs were prepared using aqueous silk sponges [194] with
dimensions of 8 mm x 3 mm at a density of 10 x106 cells/mL. For both constructs, sterile
scaffolds were placed in 24-well plate, seeded with hMSCs and placed in the incubator.
Following 2 hours, additional growth medium was added to the wells. After 24 hours, the
medium was replaced with osteogenic medium containing DMEM, 10% FBS, 0.5%
antibiotic/antimycotic, 100 nM dexamethasone, 10 mM, β-glycerophosphate, and 0.05
mM ascorbic acid 2-phosphate (Sigma, St. Louis, MO).). 48 hours post-seeding, one
osteogenic construct was placed in the e-incubator, while the other was maintained in a
standard incubator. For studying both constructs simultaneously inside the e-incubator,
the silk scaffold was punched into a 5 mm diameter.
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4.2.2 e-Incubator design
The MRI-compatible e-incubator (patent pending; application number:
13/953,984) [195] provides an enclosed but autonomously controlled and userconfigurable environment for tissue culture and development in vitro (Figure 4). A key
feature of the e-incubator is its ability to operate in a stand-alone manner through the use
of an MCU. By integrating both hardware and software, MCUs are embedded as brains in
almost all smart devices, from consumer electronics to automobiles to medical systems.
Because of its versatility and relative cost effectiveness, the Microchip PIC® MCU
(Microchip Technology Inc., Chandler, AZ) was used to control the e-incubator, thus
eliminating the need for complimentary hardware and software. The e-incubator design is
built upon the most general incubation environmental parameters, including temperature,
CO2, pH, and nutrient/waste exchange. The incubation system was fabricated from a
polycarbonate, autoclavable, tissue imaging (TI) culture chamber constructed on top of a
support chamber; the support chamber was attached to a specially designed holder
inserted into the imaging volume of the magnet. When implementing the design, the
challenge of MRI compatibility was specifically addressed. For instance, the design
required that the internal environment inside of the TI chamber, as shown Figure 4-1, can
be detected and adjusted with minimal MR magnetic susceptibility artifacts. The solution
was to use an MRI-compatible, fiber optic temperature probe (Small Animal Instruments,
Inc., Stony Brook, NY) adjacent to the construct inside the inner TI chamber. An air
blowing heating system (SA Instrument, Inc, Stony Brook, NY) along with a silicone
rubber heater (O.E.M. Heaters, Saint Paul, MN) together maintained the temperature of
the culture media. A silicon rubber heater was mounted inside a heating chamber; to
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direct warm air toward the culture chamber, a flexible air duct connected to the blowing
heater was inserted from the top of the magnet’s bore. Both heaters toggled on and off
based on the temperature reported by a probe inside the media, which resulted in
maintaining the desired temperature. A gas mixing system utilized two mass flow
controllers (MFCs) (Cole-Parmer, Vernon Hills, IL) to produce a mixture containing 95%
air and 5% CO2.

Figure 4-1 Schematic of the e-incubator system where the microcontroller unit
(MCU) is the brain controlling e-incubator culture environment. The MCU initiates
the peristaltic pump to flow a predetermined level of fresh medium to the tissue
imaging chamber while the culture environment is maintained for temperature,
CO2, and pH. The system functions as follows: (i) a feedback system maintains the
CO2 level by activating two flow meters for mixing CO2 and air based on the value
recorded by the CO2 sensor positioned on the output flow from the TI chamber; (ii)
the temperature, measured by (iii), adjusts the quality of the medium through
scheduled exchange three times a day, during which time a sensor measures the pH
value.

52
The CO2 concentration is continuously monitored using a Co2 sensor (CO2Meter,
Ormond Beach, FL). The media pH is measured through a pH sensor (Atlas Scientific,
Brooklyn, NY) mounted in the middle of the media line from the culture chamber to the
media reservoir. The recorded pH was used to calibrate the media exchange intervals. A
peristaltic pump (Thermofisher Scientific, Barrington, IL) with adjustable flow rate was
used to circulate the media between the culture chamber and the media reservoir that is
kept at 37 oC and refilled weekly.
The e-incubator system incorporated signal processing of all sensors, pump and
heater driving, communication with user interface, and the data logging application using
a PIC16f1917 MCU (Microchip Technology Inc., Chandler, AZ). This is an 8 bit model
that includes 8 channels in built 10-bit resolution analog-to-digital converter (ADC). The
MCU software communicated between all sensors and other electrical and mechanical
elements via a pre-programmed C program to ensure environmental conditions (i.e.,
temperature, CO2, and pH) were properly maintained for optimal growth of the tissueengineered construct. When turning on the system for the first time, an initialization is
used in order to pump the media out from the culture chamber and replace it with fresh
media. The system includes and overheating protection circuit to shut down the heaters in
case of temperature probe failure. All data including temperature, pH value, CO2 control
system status, date, and time were shown on a liquid-crystal display (LCD) and
transferred to a personal computer (PC) using a serial port. Finally, a surveillance camera
was used for observation over the internet using a smartphone.
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4.2.3 e-Incubator Setup and loading
The e-incubator was composed of an upper tissue imaging (TI) chamber and
lower heating chamber, machined from stock polycarbonate. Initially, adapted TranswellClear Permeable (Corning Inc., Corning, NY) plate inserts were modified and positioned
within the TI chamber for containment of the tissue construct. A nylon washer and
meshing was situated on top of the insert to keep the construct from floating out of the
insert. To avoid bubbles that interfere with imaging, a new tissue holder was designed
and manufactured from polysulphone.
Prior to setup of the e-incubator all tubes and connections were placed in
sterilization pouches for a steam autoclave, including the tissue holder. In a biosafety
cabinet, the TI chamber and pH probe were sterilized with 1M NaOH for 1 hour,
followed by a 3 rinses with sterile dH2O, and loaded basic medium until setup. A sterile
250 ml Fisherbrand bottle was filled with 100 ml of osteogenic medium (as above) and
connected with the 3 hole lid. The 3 hole lid connected to medium tubing that connected
to the pH meter flow-through cell. The opposite end of the flow through cell connected to
additional tubing that was threaded through the e-incubator holder and connected to the
bottom of the heating chamber. The tubing for the gas lines were also threaded through
the holder, an affixed to the TI chamber lid after the construct was loaded. An osteogenic
construct was placed in the tissue holder inside the TI chamber and a 3-D printed lid was
placed on top to keep it within the holder. All parts were removed from the biosafety
cabinet, the medium tube placed in the peristaltic pump, gas tubes connected, and the pH
meter, heater, and temperature probe wires connected to the MCU. The MCU was turned
on and the program initiated. The chamber was attached to the e-incubator holder with
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nylon set screws and placed within the magnet. Initial imaging was performed to evaluate
placement of the chamber and tissue in the magnet.
4.2.4 Device Verification
The e-incubator samples were tested daily for four weeks with MRI by measuring
different MR parameters. Following e-incubator culture, the samples were removed from
the traditional incubator and the e-incubator, cut into two halves and tested by live-dead
assay and conventional histology. Different constructs cultured in the e-incubator were
compared by measuring different MR parameters followed by histology as detailed
below.
4.2.5 Magnetic Resonance Imaging
The tissue-engineered bone construct was loaded into the e-incubator tissue
holder, and then the 3 cm cylindrical chamber system was inserted into a 4 cm Millipede
radiofrequency (RF) imaging probe of a 9.4 T (400 MHz for protons) 89 mm vertical
bore MRI scanner (Agilent, Santa Clara, CA), equipped with 100 G/cm maximum triple
axis gradients. The construct was positioned in the center of the magnet to ensure the best
magnetic field and MR signal. The tissue-engineered construct was imaged daily using a
fast-spin-echo sequence, the T1-relaxation time was recorded using a saturation recovery
spin-echo imaging sequence, the T2-relaxation time was recorded using a spin-echoimaging sequence, while the apparent diffusion coefficient was measured using a
diffusion weighted imaging spin echo based sequence. For the single slice fast spin-echo
(FSEMS) the following parameters were used: 2000 ms repetition time (TR), 20 ms echo
spacing (ESP), 4 echo train length (ETL), 2562 image matrix, 1 mm slice thickness, and
25 mm square field-of-view (FOV), and 64 averages (NEX). T1 was measured in seven
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steps with minimal echo time (TE = 9 ms), TRs of 50, 100, 200, 500, 1000, 2000, and
4000 ms, and 1282 image matrix .The spin-echo sequence was acquired with a similar
FOV and slice thickness and the following parameters were used: 4000 ms (TR), 10 ms
echo time (TE), 64 equal spacing echoes, and 1282 image matrix. Finally, ADC data were
generated by acquisition of a series of spin-echo- diffusion-weighted images. TR = 1000
ms; TE = 27.04 ms. The diffusion gradient was applied in the readout direction with 12
b-values of 0-1200 s/mm2, diffusion gradient duration (δ) of 3 ms, and a separation (Δ) of
18 ms were used. For quantitative MR analysis, T1,T2 , and ADC were extracted and
averaged over the entire construct from the experimental data using a least squares single
exponential fitting implemented by MATLAB ( MathWorks inc., Natik, MA) [1]. All
quantitative data were expressed as the mean ± standard deviation of all the pixels within
the construct.
4.2.6 Histology
Following 4 weeks of growth in vitro, the e-incubator specimen along with the
osteogenic construct grown in the incubator, were cut in half, rinsed with PBS, with half
placed in 10% buffered formalin. The remaining half was used for live-dead assay.
Constructs were then embedded in paraffin and sectioned. Sections were stained with
hematoxylin and eosin (H&E) and von Kossa to examine mineralization and calcium
deposition.
4.2.7 Live-dead assay
The remaining half of each tissue construct was treated with a LIVE/DEAD
Viability/Cytotoxicity Kit (Invitrogen, Carlsbad, CA) used according to the manufactures
instructions. Briefly, PBS rinsed constructs were placed in the calcein/ethidium bromide
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mixture for 1 hour, then rinsed and viewed on an Inverted Confocal Microscope IX81
(Olympus, Lehigh, PA). Live cells emitted fluorescent green and dead cells show red.
Comparisons were made between the e-incubator and standard incubator cultured
constructs. ImageJ Software (NIH) was used to count the live/dead cells and comparisons
were made between both constructs.
4.3 Results
A feasibility study was initially conducted in order to confirm that the e-incubator
mechatronics inside the magnet did not affect MRI sensitivity in detecting bone
formation. The data from this preliminary study are presented in Figure 4-2. The viability
and growth of the construct was validated using MRI. The lower signal intensity in the
construct at week two suggests increased mineralization [Figure 4-2b vs. Figure 4-2a].
Additionally, Figure 4-2c demonstrates that the temperature, pH, and CO2 were adjusted
automatically and recorded continuously during the culturing process.

Figure 4-2 Preliminary results of a smart incubator prototype using hMSC and a
gelatin scaffold. Axial MRI magnitude images of hMSC derived TEB gelatin based
construct at week 1 (a) and week 2 (b), acquired by a fast spin-echo (FSE) sequence
with same acquisition parameters; the in-plane resolution is 97 micron square. Note
that due to media exchange, the position of the construct is slightly different from
week one to week two. (d) 24-hour time course of temperature (maintained at
around 37 oC), pH, and CO2 (5%) inside the TI chamber. The sharp drops of CO2
represent media exchange, which is scheduled to occur once every six hours.
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Data analysis revealed a temperature mean of 36.1 C, a CO2 concentration of 5.24%, and
a pH level of 8.25 for the e-incubator. The data was processed to view sampling at every
10 minutes. During the media changes every six hours, the temperature reading decreased
because the temperature probe was no longer in media. Furthermore, CO2 decreased as
the gas was turned off to prevent cooling.

Figure 4-3 Culturing tissue engineered bone for four weeks in the e-incubator. (a)
Daily MR magnitude images of hMSC derived TEB silk based construct cultured in
the e-incubator for 28 days. Axial MR magnitude images were acquired using a FSE
with the following parameters: TR = 1 s; ESP = 20 ms; ETL = 4; slice thickness =
0.5 mm; FOV = 2.3 cm square; in-plane resolution = 62.5 μm × 62.5 μm; NEX = 8.
(b) Generated graphs of the daily MR parameters: T1, T2, and ADC for TEB silk
based construct for 28 days of tissue development. For each sample, T 1, T2, and
ADC decay curve consisting of signal versus TR, TE, or ‘b’ values were extracted
from the entire TEB construct. All data are presented by averages ± standard
deviation of the values within the constructs. (c) The fluorescence micrographs for
the e-incubator construct treated with the live/dead assay express viable cells green
and non-viable cells red, similar to the control construct cultured in standard
incubator (data not shown). Scale bar = 50 microns.
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Following the feasibility study, a protein silk based TEB construct was grown in
the e-incubator for four weeks. Daily MR magnitude images are presented in Figure 4-3a.
The corresponding daily acquired MR parameters including T1 and T2 relaxation times
and apparent diffusion coefficient (ADC) are presented in Figure 4-3b. Following four
weeks of culturing inside the magnet, cell viability inside the construct was confirmed
using a scanning laser confocal microscopy for both the e-incubator and the control
incubator tissues. The live/dead staining assay was used to label the viability of the
hMSCs. Calcein-AM dye stained live cells green, and ethidium homodimer dye stained
dead cells red. Confocal micrographs showed that the majority of cells for all groups
were alive and visible with equivalent staining of live/dead cells in the osteogenic groups
for the constructs grown in both the incubator and e-incubator, as shown in Figure 4-3c.
The T2 relaxation times reduced from 118 ms on week 0 to 90 ms on week 4 (20
% reduction) which was notably different than the results shown for gelatin based TEB
measured previously [1]. These results initiated a comparison study between gelatin and
silk based TEB constructs. The culture chamber was modified to hold two constructs
grown simultaneously in the e-incubator. Sample MR magnitude images are shown in
Figure 4-4a. The corresponding daily measured MR parameters are presented in Figure 44b. There was only a significant difference between the measured T2 times between the
two TEB constructs (reduced from 117 ms on week 0 for both constructs to 95 ms and 60
ms for gelatin and silk base constructs, respectively). Finally at the end of the four weeks
culture period, comparative histology for the gelatin and silk constructs grown in a
standard incubator and the e-incubator was performed as shown in Figure 4-4c. The
histologic slides of both groups grown in the e-incubator and incubator were similar with
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a lightly increased mineralization for the e-incubator group over the incubator group as
demonstrated by the larger number of black stains on the von Kossa slides.

Figure 4-4 Comparing the development of two tissue engineered bone constructs
grown simultaneously in the e-incubator. (a) Sample MR magnitude images of TEB
silk and gelatin based constructs cultured in the e-incubator for 28 days. Axial MR
magnitude images were acquired using a FSE with the following parameters: TR =
1 s; ESP = 20 ms; ETL = 4; slice thickness = 0.5 mm; FOV = 2.3 cm square; in-plane
resolution = 62.5 μm × 62.5 μm; NEX = 8. (b) Graphs of the daily MR parameters:
T1, T2, and ADC for TEB constructs in a silk scaffold (triangles) and gelatin
(squares) for 4 weeks of tissue development. (c) Comparative histology for the TEB
gelatin and silk based constructs grown in a standard incubator and the eincubator. H&E histology displayed nuclei stained blue/violet, cytoplasm purple,
and collagen pink (column 1). The von Kossa staining indicated mineral deposits
with black stain (column 2). Scale bar = 50 microns.
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4.4 Discussion
A feasibility study was initially conducted in order to confirm that the This study
demonstrates the feasibility of growing tissue-engineered constructs inside the eincubator while continuously monitoring and assessing growth via MRI and using
different scaffolds and culturing methods. Importantly, the electronics of the e-incubator
do not reduce the quality of the MRI data collected. In gelatin-based constructs,
osteogenesis reduces the values for the T2-relaxation time by 60% due to ECM
mineralization. The T2 values are correlated with osteogenic markers, including ALP
activity in a previous study [1]. For the gelatin based TEB, the T2 was approximately 120
ms at the beginning of tissue culture and reduced to approximately to 65 ms after four
weeks of culture. In a previous study measuring T2 relaxation time, the T2 values reduced
from 67 to 24 ms (approximately 60% for both methods), reduced measured values are
due to the stronger magnetic field (11.74 T compared to 9.4 T) which reduces the
measures T2 relaxation times.
However, the previous study was performed at discrete time points where
constructs were sacrificed weekly. In our study, the e-incubator offers prolonged
assessment of the same construct, which reduces data inconsistency and scattering due to
sampling and dramatically reduces statistical power during hypothesis testing.
Importantly, the ability to conduct continuous MRI assessment is expected to allow for
the investigation of different MRI contrast mechanisms (e.g., mechanical measurement,
diffusion, spectroscopy, magnetization transfer ratio, etc.) and link these contrast
mechanisms to the structure, composition, and function of tissue-engineered constructs.
Having such capability has the potential to speed the translation of tissue-engineered
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products to the clinic. Additionally, such a device can provide critical clinical
applications because it offers the opportunity for an intervention. For example, changing
the culture environment through the replacement of growth medium or the introduction of
mechanical forces through shear flow is highly feasible.
To study the effect of scaffold type on osteogenesis, we cultured osteogenic
constructs in both silk- (~500 µm pores) and gelatin- (~250 µm pores) based scaffolds
simultaneously in an e-incubator study for four weeks. Only the T2 value was different
between the two constructs. The T2 was selected as an indicative MRI parameter and it
was previously correlated with ALP activity [1]. The T2 was approximately 120 ms for
both constructs at the beginning of tissue culture and reduced to approximately to 90 ms
for the silk-based construct and 65 ms for the gelatin-based construct. We concluded
from this study that MRI parameters are dependent on scaffold type, primarily due to the
variation in porosity. This can also be seen on the histologic slides where even though
bigger chunks of black stains, indicating mineral deposition, can be noticed on the silk
scaffolds, higher deposited quantities can be noticed on the gelatin scaffolds.
The detailed imaging assessment technique is expected to provide a basis for
creating high-quality, tissue-engineered constructs by non-destructively identifying
molecular fingerprints in constructs and selecting suitable constructs with the osteogenic
phenotype for implantation. Throughout the culture period, certain molecular markers are
expected to be expressed, along with osteogenic differentiation in MSC-derived tissueengineered bone constructs cultured in the e-incubator. For example, OPN expresses in
the early stage of developing bone cells prior to mineralization or OCN expression [196].
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Therefore, future studies can be used to correlate MR findings with different osteogenic
markers.
Limitations of the e-incubator include the physical regulatory effects of magnetic
fields (static and gradients) on cells. It is possible that the high-field MR will influence
the development of constructs if the tissues are constantly retained inside the MRI
scanner; the physical regulatory effects of MR (strong magnetic field) on cells are not
well understood. Similarly, one particular study reported that magnetic and electrical
fields may alter osteoblastic proliferation and differentiation [197]. In future studies, if
the growth of tissue-engineered bone is affected, then the e-incubator should only be
placed inside the magnet during imaging sessions. On the other hand, if the presence of
the magnetic field and alternating imaging gradients affects osteogenesis, imaging
sessions duration should be optimized to enhance engineering outcome. In our future
studies, we will examine the effect of the alternating magnetic field gradients, as well as
compare different scaffolds. Importantly, the model of a MRI-compatible incubation
system used for culturing tissue-engineered bone constructs may help create other
culturing systems for other biological tissues such as tissue-engineered cartilage [198]
and neural stem cells [199].
Integration of the e-incubator with MRI can potentially allow for the
establishment of critical check points to identify osteogenic markers that confirm the
stability of the phenotype and genotype prior to implantation. In turn, the e-incubator
with MRI capability is expected to increase the success rate for tissue-engineered
constructs through its ability to filter deficient constructs. This is particularly applicable
in the ability of the e-incubator to help monitor and steer tissue-engineered bone
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constructs designed for unique needs of individual patients. Overall, this application has
the potential to advance tissue-engineered bone techniques to clinical practice.
Furthermore, while bone is used as a model system, the e-incubator itself is expected to
have applications in a range of tissue-engineered constructs, including skin, organ tissue,
and even tumorigensis and cancer treatment.
The increasing use of bioreactors in tissue engineering indicates that control and
manipulation of the culture environment becomes as important as the choice of cell or
scaffold. Future design should incorporate physiological mechanical stress into the eincubator system to create a bioreactor for bone tissue engineering. Perfusion flow and
micro-mechanical ultrasound stress can both be used to transform the e-incubator to an
MR compatible bioreactor [200, 201]. The e-incubator can be integrated with multiple
imaging modalities, thus providing different contrast mechanisms and spatial resolution.
For example, the e-incubator has the potential to improve our understanding of
tumorigenesis by providing continuous assessment of cellular to organ levels during this
process. Similarly, as the e-incubator could be used to continuously assess therapeutic
efficacy. Thus, the e-incubator has the potential to transform practices in multiple
biomedical sciences ranging from tissue engineering and regenerative medicine to cancer
research.
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CHAPTER 5
MONITORING BONE REPAIR IN A MOUSE CALVARIAL DEFECT MODEL USING
MULTIMODAL IMAGING

5.1 Introduction
Treatment of bone disease and/or severe bone damage typically involves the use
of bone grafts and surgical reconstruction. Still, several difficulties can arise from bone
grafts, including morbidity at the donor site, infection, immune system reactions, and
exposure to infectious agents [202]. To overcome difficulties associated with bone grafts,
researchers have long been investigating the potential of tissue-engineered alternatives.
To engineer bone tissue, a combination of cells, a biocompatible scaffold, and signaling
molecules are used to create bone substitutes [24].
Evaluating in vitro data from tissue-engineered bone (TEB) studies allows for
extraction of useful information, but the experimental conditions cannot be truly
replicated in the in vivo environment. Hence, animal models are critical to assess the
biological activation of osteogenesis, osteoconduction, osteoinduction, mass transport,
and biophysical effects during bone regeneration [203, 204]. Importantly, one widely
used model to study bone regeneration is the critical-sized calvarial defect mouse model,
for which naturally regenerated bone occurs at a rate of less than 10% during the lifetime
of the animal [205]. This model is of particular value for studying the development of
TEB in native conditions and the ability of TEB to promote repair of a discontinuous
lesion [204]. Notably, the defect site has easy surgical access, requires no fixation, and
creates a uniform, easily reproducible, standardized defect [204]. Calvarial defect studies
are performed using a broad range animal models including mice [206], rats [207],
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rabbits [208], or large animals including dogs [209], sheep [210], or pigs [211]. Large
animal models are of greater clinical relevance given that their skeletal maturity more
closely resembles that of humans [203].
Currently, most related experiments assess the development of engineered tissue
throughout the course of the study at predetermined intervals. Animals are sacrificed for
each examination time point in order to compare changes in longitudinal growth [37].
Excised tissues from the sacrificed animals are subjected to histology,
immunohistochemistry (IHC), real-time polymerase chain reaction (RT-PCR), and micro
computed tomography (μCT) [38-40]. In order to reduce the number of animals necessary
for statistical significance and reduce data scattering, a non- and/or less-invasive
alternative is needed that does not require animal sacrifice.
Imaging modalities, such as ultrasound, computed tomography (CT), nearinfrared (NIR) optical imaging, and magnetic resonance imaging (MRI), are nondestructive, permitting serial observations at discrete time points on the same animal. For
example, ultrasound is suitable for early stages of detecting bone regeneration, but mature
bone cannot effectively be penetrated with acoustic waves [41]. CT, on the other hand,
provides 3-D structural images with high spatial resolution and penetration depth and is
clinically translatable for late stages of regeneration through assessing the integration and
connectivity of TEB with the host bone tissue. However, CT has limited sensitivity for
pre-mature/immature bone and bone-like tissues. Also, the radiation from CT has been
found to suppress growth and induce breakdown in mouse bone [37, 42]. On the other
hand, molecular optical imaging relies on a source of contrast from fluorescence,
bioluminescence, absorption, or reflectance [212] . Fluorescently-labeled targeted probes
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that emit signals in the NIR region (700-900 nm) of the spectrum utilize lower tissue
absorption coefficients and result in deeper light penetration compared to imaging at
visible wavelengths. Alternatively, bioluminescence imaging utilizes luciferase gene
expression systems that emit visible photons based on energy-dependent reactions
catalyzed by luciferases. For example, Degano et al. (2008) used bioluminescence to
study calvarial bone repair in a mouse defect model based on manipulation of the cells
for gene insertion, verification of gene expression, and expansion of the cells with gene
expression [213]. In a previous study of TEB implanted in a subcutaneous mouse model,
NIR dye-labeled targeting agents, IRDye® 800CW BoneTagTM (800CW BT), targeted
mineralized bone or hydroxyapatites and effectively identified bone growth [214].
Relatedly, MRI provides high spatial resolution and detects changes in the water content
of tissue, thus revealing alterations of the structure and/or functions [37]. Although each
imaging modality provides information on the tissue engineering process, no single
imaging modality fully characterizes the complex remodeling process of TEB.
This paper presents a feasibility study for the application of noninvasive multimodal imaging, MR and optical imaging, to assess TEB that is implanted into a criticalsized (5 mm) calvarial defect mouse model. Each mouse served as its own control, with
the contralateral side of the cranium was grafted with a silk protein implant without cells.
NIR optical imaging with 800CW BT and MRI were used to evaluate the implant
environment for bone regeneration and/or mineralization in vivo for six months. At three
time points (i.e., two, four, and six months post implantation) implants were harvested
and analyzed using histology. CT was used to assess the regeneration at study completion
for one representative mouse.
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5.2 Experimental
5.2.1 Tissue-Engineered Bone (TEB)
Human mesenchymal stem cells (hMSCs), isolated from fresh adult human bone
marrow obtained commercially (Lonza, Walkersville, MD) were suspended in growth
medium in a T-75 flask. The medium was composed of Dulbecco’s Modified Eagle’s
medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum
(FBS; Invitrogen, Carlsbad, CA), and 0.5% antibiotic/antimycotic (Sigma-Aldrich, St
Louis, MO), and placed at 370C and 5% CO2. The media was changed twice weekly, and
cells were passaged up to five times prior to seeding. Aqueous protein silk sponges with a
pore size of 400-500 μm, a diameter of 5 mm, and a thickness of 2-3 mm, were prepared
as previously reported [194]. The sponges were next autoclaved, placed in the medium
described above, and conditioned for at least four hours. Following this, two silk
scaffolds were placed in a 24-well plate and seeded with hMSCs at a density of 1 million
cells in 35 μl of medium. Following two hours of incubation, osteogenic growth medium
containing DMEM, 10% FBS, 0.5% antibiotic/antimycotic, 100 nM dexamethasone, 10
mM, β-glycerophosphate, and 0.05 mM ascorbic acid 2-phosphate (Sigma-Aldrich) was
added to the wells. TEB was cultured in osteogenic media for two weeks prior to
implantation. On the day of surgery, sterile silk scaffolds and TEB were thinly sliced < 1
mm, placed in phosphate buffered saline (PBS), and maintained in sterile conditions at
37 0C until surgical insertion.
5.2.2 Mouse Critical-Sized Calvarial Defects
All animal procedures were performed using protocols approved by the
Institutional Animal Care and Use Committee at the University of Nebraska - Lincoln
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(UNL). Following UNL guidelines for animal usage, five 8-week-old male nude
immunodeficient mice (n = 5) (nu/nuJ; Jackson Laboratories, Bar Harbor, ME) were
anesthetized using 2% isoflurane. An iodine solution scrub was used to sterilize the
surgical area prior to surgery. A sagittal midline incision was performed to reveal the
underlying bone, and the periosteum was removed. A 5 mm stainless steel trephine (Fine
Science Tools, Foster City, CA), attached to a drill (Dremel, Racine, WI), generated two
contralateral defects per animal, one on each side of the calvarium (Figure 5-1) [38].

Figure 5-1 Schematic drawing of mouse calvarial defect for surgical insertion of silk
scaffold (left side) and tissue-engineered bone (right side) implants.
Care was taken to ensure the dura remained intact during drilling and calvarium removal.
Forceps were used to place the silk scaffold and TEB on the left and right defects,
respectively. Using nylon surgical sutures, the incision was closed, and the animal
removed from isoflurane exposure. Following surgery, mice were maintained under
aseptic conditions. Sutures were removed at one week post-surgery. Each animal served
as its own control, with the silk scaffold implant serving as the control to the TEB
implant. Of the five animals, one animal was sacrificed and evaluated at month 2, another
animal was sacrificed and evaluated at month 4, and three animals were sacrificed and
evaluated at month 6.
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5.2.3 Near-Infrared Optical Imaging
All mice were anesthetized with 2% isoflurane inhalation for all imaging
procedures. The NIR dye-labeled targeting agent 800CW BT (LI-COR Biosciences,
Lincoln, NE) was reconstituted to a dose of 2 nM per animal according to the
manufacturer’s instructions; each mouse received a 100 μl intraperitoneal injection. NIR
optical images were acquired using the Pearl® Impulse Small Animal Imaging System
(LI-COR Biosciences, Lincoln, NE). Pre-injection dorsal images (85 μm) of the mice
were acquired 24 hours post-surgery and at one-month intervals, starting at one-month
post-surgery and continued for six months. Each month, following baseline imaging,
mice were injected intraperitoneally with 800CW BT and imaged 48 hours post-injection
to allow the unretained agent to clear. For imaging at months four through six, the
implant site was shaved and treated with the depilatory cream Nair™ (Church and
Dwight Co, Inc., Ewing, NJ) to prevent interference from hair growth. Prior to month
four, hair growth was minimal. Relative fluorescent units (RFUs) for the silk scaffold and
TEB implants were recorded for each animal by placing a region of interest (ROIs) on the
defect area and analyzing it using Pearl Cam Software (LI-COR Biosciences, Lincoln,
NE).
5.2.4 Magnetic Resonance Imaging
Prior to MRI, mice were anesthetized and positioned on a custom-designed
animal holder (Agilent, Inc., Palo Alto, California). Throughout imaging, animals were
maintained under anesthesia (1.2%-2% isoflurane), with their body temperature and
respiration rate closely monitored and controlled using the Model 1025 Monitoring and
Gating System (SA Instruments, Stony Brook, NY). Both in vivo and ex vivo anatomical
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images of the tissue-engineered constructs were acquired using a 9.4 T, 89 mm verticalbore magnet (Agilent, Santa Clara, CA). For the in vivo imaging, images were acquired
with a 4-cm millipede radiofrequency (RF) coil. Micro-imaging triple axis gradients
(Agilent, Santa Clara, CA) with a maximum strength of 100 Gauss/cm and inner diameter
of 57 mm were used for all experiments. The scanning protocol first obtained gradientecho axial slices using repetition time (TR) = 300 ms, echo time (TE) = 2.5 ms, flip angle
= 25°, field-of-view (FOV) = 24 cm, and slice thickness = 0.3 mm sectioned through the
defect site to localize the constructs. Following localization, slices were obliquely aligned
orthogonal to the axial slices and tangentially to the constructs. The appropriate plane
was chosen to acquire a fast-spin-echo sequence (FSEMS) with the following parameters:
repetition time (TR)/echo spacing (ESP) = 2000/9.39 ms, echo train length (ETL) = 8,
number of averages = 16, FOV = 23 mm2, matrix size = 1282, slice thickness = 0.2 mm
and imaging time = 8 min and 36 s. Animals were imaged at zero, one, three, and six
months. Comparisons were made between the cranial images of the silk scaffold and the
TEB.
At six months post-surgery, one mouse was sacrificed; the head was fixed in
10%-buffered formalin and imaged using the parameters listed above followed by CT
imaging (described below). Following the imaging of the fixed head, the implants were
excised, placed in formalin, and imaged with a 10 mm RF coil. To increase the signal-tonoise ratio, a 10 mm, custom-designed RF coil was used in combination with a magnet.
To acquire high-quality images with a short echo time (TE), a gradient-echo sequence
was employed to contrast the silk scaffold and TEB. The applied parameters for the
gradient-echo sequence were TR = 500 ms, TE = 3.19 ms (minimum); flip angle = 25º,
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number of averages =16, FOV = 21 mm2, matrix size = 128×128, slice thickness = 0.2
mm, and imaging time = 4 s and 17 min. MRI magnitude images were compared to
calculate the difference in signal intensity for the silk scaffold and TEB.
5.2.5 Computed Tomography
After six months of regeneration, the head of one representative mouse was
decapitated and fixed. The entire cranium/head was imaged using CT. Image acquisition
was accomplished using a FLEX Triumph X-ray computed tomography/single photon
emission system (CT/SPECT) (Gamma Medica, Inc., Salem, NH). Data was analyzed
using software (TriFoil Imaging, Inc., Northridge, CA) to assess the extent of the
regeneration after six months, and 1,024 CT projections with three frames per projection
were acquired at 60 kVp and 210 µA with a focal spot size of 50 µm. These CT/SPECT
projections were reconstructed at an optimum resolution option using Triumph X-O 4.1
(Gamma Medica, Inc, Salem, NH). The matrix size was 512 µm, and the voxel size was
180 µm. Images were generated using visualization and analysis software VIVID, which
is based on Amira 4.1 (Visualization Sciences Group, Germany).
5.2.6 Histology
At two-, four-, and six-month intervals, an animal was sacrificed, and the tissue
was excised from each defect site. Samples were fixed in 10%-buffered formalin and
processed for paraffin embedding at the UNL Nebraska Veterinary Diagnostic
Laboratory. Samples were sectioned (5 μm) and stained with hematoxylin and eosin or
von Kossa stain. All slides were examined by a certified pathologist and imaged with a
light microscope AX70 (Olympus, Center Valley, PA).
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5.3 Results
5.3.1 Optical Imaging
At 72 hours after surgery and 48 hours after 800CW BT dye injection, NIR
optical imaging revealed probe retention. The data was excluded at month zero because
inflammation at the defect sites biased the optical images. At the one-month time point,
defects were clearly visible in all mice (n = 5) with the TEB, displaying higher signal
intensity (RFUs) than the control implant. During the entire bone development period,
defects were clearly visible in all mice, with the TEB implants displaying higher RFUs
than the silk scaffold control implants. The strongest signal intensity occurred at month
two. Figure 5-2 presents the NIR optical images of a mouse at one-month intervals,
ranging from one to six months. It should be mentioned that pre-injection baseline
imaging did not occur for month one, and the data from that month could not be used for
quantitative but rather for qualitative representation. ROIs (Figure 5-2; circles) indicate
the ROI for assessing bone growth/mineralization. The control (left side) and the TEB
(right side) were analyzed to determine the binding of 800CW BT (Figure 5-3).

Figure 5-2 Near-infrared optical images for study mouse at one-month intervals,
starting at month 1 up to 6 months. The images at each interval were taken at 48
hours post-injection. Circles indicate the region of interest (ROI) examined for
intensity of relative fluorescent units (RFU). The left circle indicates the site of silk
scaffold (i.e., control), and the right circle indicates the tissue-engineered bone
(TEB) implants.
At month two, the data revealed peak fluorescence for TEB, with RFU = 0.66. There was
a constant RFU for months three through five (RFU = 0.59, 0.57, and 0.58, respectively)
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and a decline to 0.44 at month six. Along with peak fluorescence at month two of
imaging, all mice exhibited a higher deposition of 800CW BT in the TEB compared to
the control.

Figure 5-3 Evaluation of the region of interest (ROI) showing the relative
fluorescent units (RFU) for pre-injection and 48 hour post-injection for defect sites,
starting at month 2 up to 6 months.
5.3.2 MRI and CT
5.3.2.1 In Vivo Imaging
MRI of the control and TEB implants were acquired at three time points during
the study. Figure 5-4a illustrates how the slice was aligned for imaging of the defect sites.
MRI magnitude images of the control and TEB implants are shown in Figure 5-4b, where
images from the same mouse are shown for different growth stages are shown. With
respect to regeneration, both implants exhibited a decrease in signal-to-noise ratio (SNR).
The control SNR was higher compared to the TEB, however, the control SNR also
decreased as the study proceeded.
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Figure 5-4 MRI magnitude images of the control and TEB constructs at three time
points. (a) Alice alignment: Images were acquired in oblique planes touching the
constructs and cutting through them with a slice thickness of 0.3 mm. (b) MRI
magnitude images of the control and TEB constructs at different growth stages
acquired using a fast-spin-echo (FSE) sequence. The constructs are outlined by
white dashed contours. Gated Images show that the decrease in the MR SNR for the
TEB construct is more than the control. Acquisition parameters were TR=2000 ms;
ESP=9.39 ms; ETL=8; Average=16; Matrix=1282; FOV=23 mm2; acquisition time=
8min and 36 sec.
5.3.2.2 Ex Vivo Imaging
After six months of regeneration, one mouse (out of three) was sacrificed; the
head was removed and placed in 10% buffered formalin. Figure 5-5a shows the control
and the TEB implants in the fixed mouse head. Both implants appear integrated with the
native tissue. However, the CT image (Figure 5-5b) revealed the control implant covered
approximately 40% of the defect site, while the TEB covered approximately 80% of the
defect site. MRI magnitude images (Figure 5-5c and d) resulted in a SNR of 11.6 for the
TEB and 26.5 for the silk scaffold, indicating greater mineralization in the TEB implant.
Higher quality MRI magnitude images were acquired by excising the constructs and
capturing images using the 10 mm RF coil as shown in Figure 5-6. The resultant MRI
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magnitude images acquired by a gradient echo sequence illustrated significant difference
(SNR of 11.6 compared to 26.5) between the signal intensity of TEB compared to the
control, as shown in Figure 5-6.

Figure 5-5 (a) Photograph of excised, fixed mouse head after 6 months of in vivo
growth. (b) CT image of fixed mouse head at study completion showing the implants
for the silk scaffold control and the tissue-engineered bone (TEB). High resolution
magnetic resonance imaging (MRI) magnitude images of the (c) control and (d)
TEB. The control had a high SNR (SNR = 26.5) compared to the TEB (SNR = 11.6).
2Images were obtained with a 40 mm RF coil. TE = 3.19 ms; Flip angle = 25;
Average = 16; Matrix = 1282; Slice thickness = 0.2 mm. The implants are outlined by
white dashed circles, and the SNR is indicated on each image.
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Figure 5-6 High-resolution magnetic resonance imaging (MRI) magnitude images of
the excised tissue samples upon conclusion of the study after six months. White,
dashed circles outline the (a) Control and (b) tissue-engineered bone (TEB). Due to
mineralization of the tissue, the TEB produced a lower signal-to-noise ratio (SNR)
compared to the control. For imaging, a 10 mm RF coil was used with acquisition
parameters for the applied gradient–echo sequence imaging as follows: TR = 500
ms; TE = 3.19 ms; Flip angle = 25; Average = 16; Matrix = 128*128; Thickness = 0.2
mm; FOV = 17 min and 4 sec.
5.3.3 Histology
Mice were sacrificed at 2 (n=1), 4 (n=1), and 6 months (n=3). The calvarial
implants were excised, and the tissue was processed for histological analysis.
Hematoxylin and eosin stain was used to evaluate the composition and structure of the
implants; von Kossa was used stain to evaluate mineralization (Figure 5-7). Observations
using light microscopy showed the control implant underwent some cell migration from
the surrounding tissue, but with a large amount of un-degraded silk scaffold visible
(Figure 5-7a). In contrast, the stained sections of TEB at month 2 (Figure 5-7d) revealed
numerous cells and the presence of de novo bone. With respect to von Kossa stain at
month 2, there was minor staining in the control (Figure 5-7g) but an abundance of black
staining for calcium salts in the TEB (Figure 5-7j).
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Figure 5-7 Histological analysis of (A-C and G-I) control, (D-F and J-L) of tissueengineered bone (TEB) from excised calvarial defects at months 2, 4, and 6. (A-F)
Hematoxylin-eosin stained sections and (G-L) von Kossa stained sections. Black
arrows indicate un-degraded silk scaffold, asterisk indicates de novo bone, and blue
arrows indicate mineralization. Scale bar = 100
The control for the mouse sacrificed at month 4 incurred an infiltration of cells
and was less porous than month 2, but had a similar amount of un-degraded silk scaffold
(Figure 5-7b). The month 4 TEB (Figure 5-7e) demonstrated more new cells than month
2 and more de novo bone. Similarly, for the control, the von Kossa stain at month 4
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revealed more calcium salts compared to the month 2 sample (Figure 5-7h), and the TEB
appeared similar in structure to the month 2 sample (Figure 5-7k). Month 6 staining of
the control demonstrated cell infiltration, which appeared similar to the previous samples
(Figure 5-7c). The TEB showed cells and de novo bone, but a decreased amount of both
compared to previous months (Figure 5-7f). The von Kossa staining at month 6 for the
control (Figure 5-7i) had a similar amount of calcium deposition as month 4. Also, the
TEB at month 6 exhibited less calcium salts compared to month 4 (Figure 5-7l).
5.4 Discussion
The aim of this study was to evaluate the feasibility of applying multi-modal
imaging in order to noninvasively assess in vivo growth of a pre-cultured TEB in a
critical-sized defect mouse model. Noninvasive imaging modalities of NIR optical
imaging using 800CW BT and MRI, as well as endpoint measurements of histology and
ex vivo CT, were used to analyze the bone growth and mineralization. This study is
unique in that it maintained the implants for six months in vivo, and the serial images
obtained with both modalities confirmed changes in the TEB growth and mineralization.
Histological findings for bone formation specifically supported the NIR optical imaging
findings, showing a decrease in bone growth as in vivo development progressed to six
months. This decrease suggests additional strategies are needed to optimize the
regeneration process and improve vascularization. For example, more sophisticated
culturing techniques may be applied to incorporate cross-talk between MSCs and
hematopoietic stem cells (HSCs) for optimal growth and vascularization [215]. Most
studies on TEB implanted into a mouse critical-sized calvarial defect model take place
for only up to 12 weeks [38, 213, 216, 217]. In our study, a significant regeneration of the
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TEB was identified after two months of culture, similar to most studies, but continuous
monitoring on the regeneration process up to six months showed an unexpected plateau,
and even decrease, of NIR optical imaging signal intensity in the TEB. This implies that
eight weeks may not be a sufficient time frame to fully evaluate and assess the TEB
regeneration process.
For NIR optical imaging, mice were administered a NIR-labeled agent, 800CW
BT, which is specific to bone tissue, and imaged at one-month intervals. This technique is
ideal for evaluating mouse calvarial defects because the defect site is only a few
millimeters in depth, and thus, the light absorption and scattering of NIR waves are
reduced compared to visible wavelengths, enabling noninvasive analysis of the bone
remodeling and mineralization [218, 219]. The 800CW BT used in this study was
previously evaluated with an assay to compare undifferentiated hMSCs and an
osteogenically differentiated hMSCs in a monolayer. In this previous evaluation, results
showed preferential binding and statistical significance, with the signal intensity 4.45 to
7.75 times higher for the differentiated cells. Such results were confirmed with positive
calcium staining using von Kossa [220]. In our study, all animals at all intervals
demonstrated a higher RFU signal in the TEB than compared to the control; the RFU
peaked at month 2. The results from the NIR optical imaging of calvarial defects showed
mineralization in the TEB implant, which also peaked at month 2; however, the signal
intensity from the animals sacrificed at month 6 were not consistent. We posit that these
findings resulted from the quality of the TEB samples. In order to optimize the TEB
implant, it may be necessary to use an improved cultivation system for pre-implantation
growth, as well as culture the TEB for more than two weeks. For example, Meinel et al.
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used a bioreactor to provide dynamic culture conditions for tissue-engineered constructs
for five weeks prior to implantation in mouse calvarial defect model. This strategy
resulted in the improved generation of a trabecular-like network in the TEB implant [38].
To compare the signal intensity of the control and TEB implants, MRI was used
to evaluate the calvarial defect implants noninvasively at specific time points. Compared
to NIR optical imaging, MRI magnitude images indicated decreased signal intensity
between TEB and control implants at each imaging interval. Additionally, the intensity
decreased between the intervals (e.g., at month 0, TEB and control SNRs were greater
compared to month 3). Previously, MRI was successfully used to monitor in vitro growth
of TEB, showing a statistically significant decrease in T2-relaxation times from increased
deposition of minerals and extracellular matrix. Additionally, these results are supported
by histological findings with von Kossa staining, which indicated extensive calcium
deposition [1]. Results reinforce that MRI can be used to assess bone growth in an in vivo
mouse calvarial defect model. Notably, MRI results were in alignment with NIR optical
images up month 2. However, the MRI SNR of the TEB and the control continued to
decrease following month 2. This SNR decrease can be interpreted as non-specific
calcified tissue development within the TEB and the control. X-ray diffraction has been
used to assess the crystalline nature of the deposited bone tissue in TEB in vitro [38] and
should be applied in future in vivo studies where implants can be extracted to assess the
quality of mineralization. Preliminary CT data demonstrated that the TEB implant
covered a larger area of the defect compared to the control. However, segmentation
algorithms are needed to differentiate mineralized from non-mineralized tissues [38].
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The control and TEB evaluated in a critical-sized calvarial defect showed
apparent histological differences between the observed animals. For example, the
osteogenic implant showed an abundance of cells, with the most visible at the month 4.
The control had some cellular integration from the surrounding native mouse tissue. The
TEB showed de novo bone at all intervals of 2, 4, and 6 months. The control exhibited a
small amount of de novo bone at month 4, suggesting host cells integrated into the silk
and produced developing bone, which was also supported by mineralization in the von
Kossa results. The von Kossa results from the TEB corroborated the findings from the
NIR imaging, showing a peak in bone growth at month 2, with a small decrease for
months 3-5 and a greater decrease at month 6.
To improve results obtained from this feasibility study, it is necessary to verify
and enhance the quality of TEB implanted into the defect model. Use of a spinner flask or
a bioreactor for the pre-implantation culture is expected to increase the quality of the
tissue. Additionally, in order to provide an even distribution of hMSCs, improved seeding
methods could be used for the silk scaffold dimensions rather than the sectioning and
implanting it immediately prior to surgery. Furthermore, it may be necessary to verify the
quality of the TEB prior to surgery. Empty defect control with no scaffold can be used to
compare with TEB regeneration in future studies. Based on this study, fiduciary markers
are needed to register images acquired via different modalities, and more comprehensive
TEB evolution can be recorded. The same fiduciary markers can be used for the imaging
modalities to improve replication of animal positioning as the animals grow.
In conclusion, this study demonstrates the feasibility of multi-modal imaging
using NIR optical imaging and MRI to noninvasively evaluate TEB growth in critical-
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sized calvarial mouse defect implants. With some modifications to the current study, as
discussed above, these imaging modalities can be used to provide improved results for
future studies and for translating the new methods to clinical studies. NIR imaging with
800CW BT can effectively visualize hydroxyapatite (HA), a good biological osteogenic
marker. MRI was effective for anatomical imaging, as well as for visualization of
collagen through the identification of different markers using advanced imaging
techniques, such as the magnetization transfer ratio. Finally, CT with proper threshold
and segmentation routines can be used to visualize integration and connectivity of TEB
with the host bone.
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CHAPTER 6
MRI-GUIDED EVALUATION OF CARTILAGE TISSUE ENGINEERING IN VIVO
6.1 Introduction
Cartilage abnormalities such as degeneration of the joint's cartilage due to primary
osteoarthritis, injury to the articular cartilage, inflammation, and genetic disorders affect
almost 30 percent of Americans [221, 222]. Cartilage is a form of connective tissue, with
regard to its molecular structure, and consists mainly of water, collagen, proteoglycans,
and cells [223]. Articular cartilage, specialized to provide a smooth surface for joints, is
composed of 65-75% water, 14-20% collagen, and 5-15% proteoglycans [223-225].
Repair of cartilage defects remains a challenging problem due to the biological features
of cartilage tissue, such as limited blood supply, lack of self-repair capacity [226] and
defective immobilization [227]. Tissue engineering and stem cell therapy hold great
potential of being able to restore, repair, and replace damaged or lost cartilage tissue
[228]. Human mesenchymal stem cells (hMSCs) have been used successfully to
differentiate into a wide range of cells, including osteoblasts (bone cells) [229],
chondrocytes (cartilage cells) [230], and adipocytes (fat cells) [231], depending on
culture conditions. To regenerate functional tissues and organs, three-dimensional
scaffolds have to be designed to prepare attachment sites and bioactive signals for growth
and differentiation of cells into a desired lineage [232]. Collagen (the main constituent of
skin, cartilage, bone, and connective tissue) and gelatin, which is a derivative of collagen,
have been widely employed in cartilage tissue engineering as scaffolds [233-236].
Another scaffold that has been used for encapsulating chondrocytes in cartilage tissue
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engineering is highly porous silk scaffold developed by an aqueous process as described
by Rockwood et al. [237]. Recent works have assessed the efficacy of different scaffolds
containing embedded chondrocytes or stem cells for cartilage repair [238-240]. Park et al.
reported cartilage regeneration using biodegradable oxidized alginate/hyaluronate
hydrogels and effective cartilage regeneration was observed after 6 weeks of
transplantation based on histological analysis, substantial secretion of sulfated
glycosaminoglycans, and expression of chondrogenic marker gene (Collagen II)
compared with non-degradable oxidized alginate/ hyaluronate hydrogels were observed
[241].
There is a great need for the development of effective methods for monitoring the
composition, structure, and function of the tissue-engineered cartilage in vivo. These
techniques have to be noninvasive and preferably they should provide quantitative
information at different growth stages, repair, and regeneration. Conventional
characterization of engineered constructs is carried out with a variety of tools, such as
microscopy, biochemical assays, and histologic stains. While these methods provide
critical information on tissue’s regeneration, they are destructive and result in the
sacrifice of the tested subject [242]. This results in the need to test larger numbers of
animals to compensate for data scattering in order to derive meaningful conclusions.
Noninvasive and nondestructive techniques, therefore, must be investigated which enable
one to both analyze and quantify constructs in vitro and regenerated tissues in vivo. The
materials and specimens can be evaluated longitudinally in the same animal by means of
the noninvasive techniques and analyzed by a statistical method for repeated
measurements. This reduces the number of animals, experiments costs, and allows early
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intervention and modification of experimental protocols to obtain superior engineering
outcomes. Biomedical imaging methods such as computed tomography (CT) [243],
ultrasound (US) [244], and MRI [245-247] are being applied as noninvasive means of
assessment. Among the imaging technologies, MRI has been shown to potentially play a
significant role in tissue engineering, providing nonionizing radiation, high spatial
resolution, high penetration depth, and multiple contrast mechanisms [1]. Researchers
have employed MRI-based techniques to correlate various MR-derived parameters (e.g.,
transverse MR relaxation time T2, apparent diffusion coefficient (ADC), shear stiffness,
and magnetization transfer (MT) ratio) with mineral deposition and molecular content [1,
82, 248, 249]. One recently developed contrast mechanism employs a phase-contrast in a
technique termed MRE for elasticity imaging [250-253]. MRE requires three steps to
generate quantitative stiffness maps. First, a mechanical actuator is coupled to the tissue
of interest to generate propagating shear waves through the tissue. Then, a pulse
sequence, including a motion encoding gradient (MEG), is used to encode the motion as
phase in the MR image. Finally, an inversion algorithm is employed to recover the shear
stiffness map (or elastogram) from the spatio-temporal data. MRE, while relatively new,
has been extensively developed to characterize the mechanical properties of biological
soft tissue [254-257], and also has been used for preliminary research in tissue
engineering [257-259]. MRE was transferred to the microscopic scale using high field
MRI and was employed to monitor tissue-engineered constructs regeneration in vitro and
in vivo [257, 260-264]. Mechanical properties acquired using MRE besides conventional
MRI data, such as T2, ADC, MT ratio, can be expected to play a leading role in assessing
engineered cartilage. These anatomical, biochemical, and biomechanical features can be
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extracted at different time points of cartilage growth in preclinical models to generate
sensitive biomarkers, which can help choose the appropriate time points to be used in
preliminary clinical trials.
In the current study, high field MRE and MRI are applied as noninvasive
techniques to characterize biomechanical and biological features of tissue-engineered
cartilage after implantation in an 8-week in vivo study. Three types of scaffolds,
including silk, collagen, and gelatin seeded by hMSCs and treated with chondrogenic
media, were cultured for three weeks. As the second phase, the constructs are implanted
subcutaneously into an ectopic animal model. The mice are under study for 8 weeks and
imaged at four time points. MRE and MRI derived parameters, including the MR
transverse relaxation time T2 and the shear stiffness (μ), are measured during the study.
At the conclusion of the study, expressions of cartilage-specific genes are quantitated
using real-time RT-PCR. The results of this study will provide researchers with a
noninvasive rapid-feedback method for improving the engineered outcome. The
developed method allows sacrificing less of animals needed per experiment. In a
longitudinal experiment each animal is studied as its own control, thereby enabling
repeated evaluation of cartilage features, and more measures statistics. This research will
enable the design of better tissue-engineered cartilage that can be translated into
treatment of tissue defects.
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6.2 Experimental
6.2.1 Cell culture and preparation of different tissue engineering cartilage
constructs
Healthy human bone MSCs isolated from fresh marrow cells were provided
commercially (Lonza, Walkersville, MD). Cells were cultured in a basic culture medium
composed of Dulbecco’s Modified Eagle’s Medium (Gibco, Carlsbad, CA) supplemented
with 10% fetal bovine serum (Gibco, Carlsbad, CA) and 1% antibiotics/antimycotics
(Invitrogen, Carlsbad, CA. The chondrogenesis culture medium was created by adding 10
nM dexamethasone, 40 μg/ml L-proline, 50 μg/ml ascorbic acid-2-phosphate (Sigma, St.
Louis, MO), 10 ng/ml TGF-β3 (Peprotech,Rocky Hill, NJ) and ITSTM premix
(containing 6.25 μg/ml insulin, 6.25μg /ml transferrin, 5.33μg/ml linoleic acid, and 1.25
mg/ml bovine serum albumin) (BD Biosciences, Bedford, MA) to the basic culture
medium [265, 266].
The engineering outcome will depend on the scaffold material and physical
properties, including the pore size and the scaffold composition [267]. Three different
scaffolds were selected for cartilage TE: gelatin sponges with a pore size of 250 microns
(Pharmacia & Upjohn, Kalamazoo, MI), fabricated protein silk with a pore size of 500
microns (Department of Biomedical Engineering, Tufts University, Medford, MA), and
collagen constructs with a pore size of 350 microns (Kensey Nash, Exton, PA).
Constructs were biopsy punched to a 5 mm diameter. Gelatin and collagen constructs
were seeded, in 50 μl DMEM medium, at 0.5 × 106 cells/scaffold with the assistance of a
vacuum using a 20 ml syringe [268, 269]. They then were moved to 24-well plates after
two hours. For silk scaffolds, the protocol presented by Rockwood et al. [270] was
adopted. Briefly, silk scaffolds were placed in 24-well plates, and their pores evacuated

88
with a Pasteur pipette; then, they were seeded at 0.5 × 106 cells/scaffold, which were
delivered in equal portions to the top and bottom surfaces. After 15 minutes in the
incubator, scaffolds were rotated 180°, and 10 μl of cell free medium was added to
maintain hydration. This process was repeated four times. The constructs were cultured
for 3 weeks before implantation.
6.2.2 In vivo construct implantation
The proposed animal work is approved by the Animal Care Committee at the
University of Nebraska-Lincoln (UNL). Currently, we have an approval from IACUC for
the implantation of MSC-derived engineered tissues in mice. Constructs were implanted
subcutaneously in eight-week-old male nude immunodeficient mice (nu/nuJ, Jackson
Laboratories, Bar Harbor, ME). For the implantation surgery, the mice were anesthetized
with 5 percent isoflurane. The surgical site was disinfected with betadine and isopropyl
alcohol. A 25 mm incision was made mid-sagittal across the dorsum in the prescapular
region, where a subcutaneous pocket was created on back of the midline. The constructs
were implanted and fixed in location by placing a suture through the muscle. The animals
were allowed to heal for two weeks before removing the suture and conducting
MRE/MRI measurements. The mice were examined for up to eight weeks following
implantation.
6.2.3 MRI system and measurement of MR parameters
All MRI acquisitions were conducted at 9.4 T (400 MHz for protons) using an 89mm vertical bore magnet equipped with triple axis gradients (maximum strength 100
G/cm) (Agilent, Santa Clara, CA). Measurements were acquired using a 4-cm Millipede
RF imaging probe to transmit and receive the nuclear magnetic resonance signals. T2-
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weighted images were acquired from sagittal sections for the silk construct, axial sections
for the collagen construct, and coronal sections for the gelatin construct using a spin echo
multi-slice (SEMS) sequence with the following parameters: repetition time (TR) / echo
time (TE) = 1000/13.82 ms, average = 2, matrix = 128×128 pixels, field-of-view (FOV) =
14-20 mm2, slice thickness = 1 mm. Transverse relaxation times T2 were measured by
applying multiple-echo spin echo imaging sequences to acquire 32 echoes (TR, 4000 ms;
TE, 10 ms; number of echoes NE, 32; average, 2; FOV, 14-20 mm2; matrix, 128×128
pixels; slice thickness, 1 mm). T2 values were extracted from the experimental data using
a least-squares single exponential fitting, and a low-pass filter was applied to improve the
readability of the maps
6.2.4 Magnetic resonance elastography
A modified phase contrast pulse sequence integrated with the imaging software,
VnmrJ 3.1, was used to acquire MRE data. The MRE interface allows the user to select
the MRE parameters, including gradient amplitude (0-100 G/cm), actuator frequency,
delay between the mechanical actuator and the bipolar gradient, MEG direction, and
number of bipolar pairs. The design and setup of the MRE system have already been
demonstrated by Othman et al. [257]. An actuator was designed to provide sufficient
displacement into the cartilage construct as shown in Figure 6-1a. The design was
achieved through the use of a piezoelectric bending motor (Piezo System, Woburn, MA)
secured to a curvature around the mouse. A plastic cap attached to the other side of the
piezoelectric motor was coupled to the mouse’s body adjacent to the tissue construct. The
actuator was driven by a signal generator (Tektronix, Beaverton, OR) followed by an
amplifier (Piezo System, Woburn, MA). Before placement in the scanner, the actuator
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was characterized using a Laser Doppler Vibrometer and its resonance frequency
providing the largest vibration is identified as represented in Figure 6-1b. The mice were
placed in ventral recumbency onto an especial-designed animal holder and were
maintained anesthetized with 1.5-2% isoflurane (Molecular Imaging Products Company,
Bend, OR) and monitored (Small Animal Instruments, inc., Stony Brook, NY). MRE
acquisitions were carried out with the addition of external respiration gating to reduce
motion artifacts.

Figure 6-1 (a) Experimental setup of in vivo MRE. The actuator was designed to be
placed adjacent to the tissue for maximum wave propagation into the construct. The
arched suspension design permitted the actuator to be rotated over the curvature of
the mouse’s body to optimize positioning. The current device is adapted for the
operation of 400 - 1600 Hz piezoelectric actuators. (b) Actuator characterization.
The frequency response of the actuator will be determined by sending a white noise
to the system, and performing Fourier Transform. A continuous sinusoid signal at
the resonance frequency will be delivered to the sample to determine the actuation
maximum amplitude.
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MRE scans were conducted using a spin-echo based phase contrast sequence with
TR=1000 ms, TE=19-21 ms, acquisition matrix=128×128, FOV=14-20 mm2, mechanical
frequency f=750-800 Hz, N=2 (number of gradient bipolar pulses), and maximum
MEG=95 G/cm. MRE acquisitions were carried out with six phase-offsets (between
mechanical waveform and MEG) equally spaced across each vibration cycle. Resultant
six wave images were processed using a MATLAB code based on a previously
developed spatiotemporal filtering approach to solve the inverse problem and calculate
the shear stiffness of the constructs [86, 252, 271, 272].
6.2.5 RNA extraction and cDNA synthesis
Fresh constructs were transferred into 1.5 ml centrifuge tubes. Samples were
homogenized in 1.5 ml Trizol (Life technologies,Grand Island, NY) using mortar plus
liquid nitrogen, and RNA was extracted according to the single-step acid-phenolguanidinium method [273]. The RNA samples were reverse transcribed into cDNA using
a QuantiTect Reverse Transcription Kit according to the manufacturer’s protocol
(Qiagen, Hilden, Germany). A 300 ng total RNA sample was used for the single strand
cDNA synthesis. The reverse transcription reaction was incubated at 42 °C for 30 min,
and terminated at 95 °C for 3 min.
6.2.6 Real time reverse transcription-polymerase chain reaction (real-time RT-PCR)
Agg and Collagen II transcript levels were quantified using Fast SYBR® Green
Master Mix (Life Technologies,Grand Island, NY) and the ABI Prism 7000 real time
PCR system (Applied Biosystems, Barlsbad, CA). The transcript data were normalized to
the housekeeping gene, glyceraldehydes-3-phosphate-dehydrogenase (GAPDH).
Reactions were performed in triplicate. Expression of target genes was normalized to
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GAPDH and expressed as the fold ratio relative to the control group, using the 2-ΔΔCT
method [274]. Specific genes and primer sequences are listed in Table 6-1.
Table 6-1 Amplified genes, and specific primer.
Gene

Primer Sequence

Agg

F: 5’-AGGCAGCGTGATCCTTACC-3’
R: 5’-GGCCTCTCCAGTCTCATTCTCTC-3’

Collagen II F: 5’-CGTCCAGATGACCTTCCTACG-3’
GAPDH

R: 5’-TGAGCAGGGCCTTCTTGAG-3’
F: 5’-TCCACTGGCGTCTTCACC-3’
R: 5’-GGCAGAGATGATGACCCTTT-3’

6.2.7 Statistical analysis
All data are expressed as means ± standard deviations. Statistical analysis was
performed by one-way analysis of variance (ANOVA) in conjunction with Tukey’s post
hoc comparisons for multiple comparisons with p values less than 0.05 considered
significant.

6.3 Results
The in vivo results indicate variations of imaging markers during growth and
differentiation of the chondrogenic constructs toward cartilage. Figure 6-2 demonstrates
magnitude MRI images, T2 relaxation maps, displacement fields, and stiffness maps
generated for the silk scaffold at different time points (week 2, week 3, week 4, and week
8 after implantation). Average of T2 relaxation times calculated inside the region-ofinterests (ROIs) changed from 91.2 ± 7.6 ms at week 2 after implantation to 71.6 ± 6.1
ms at week 4 and 67.6 ± 3.1 ms at week 8. Average stiffness values increased from 7.6 ±
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2.0 kPa at week 2 after implantation to 13.7 ± 4.3 kPa at week 4 and 17.2 ± 3.1 at week 8.
Measured values for the collagen construct are presented in Figure 6-3. Average T2 times
decreased from 75.2 ± 18.4 ms to 61.3 ± 7.1 ms at week 4 and 58.4 ± 4.2 ms at week 8.
Average stiffness values for the collagen constructs increased from 4.6 ± 1.7 kPa to 12.0
± 3.7 kPa at week 4 and to 14.7 ± 3.8 kPa at week 8.

Figure 6-2 Silk construct development map over an 8-week in vivo study at four time
points. Shown from left to right are the magnitude SEMS images, T2 relaxation
maps, displacement fields, and stiffness maps of the construct. Average of T2
relaxation times calculated inside the ROIs reduced from 91.2 ± 7.6 ms at week 2
after implantation to 71.6 ± 6.1 ms at week 4 and 67.9 ± 3.1 at week 8. Average
stiffness values increased from 7.6 ± 2.0 kPa at week 2 after implantation to 13.7 ±
4.3 kPa at week 4 and 17.2 ± 3.1 at week 8.
Figure 6-4a demonstrates a comparison of transverse MR relaxation times
measured for the three implanted constructs (silk, collagen, and gelatin). At week 2, T2
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times measured for the silk, collagen, and gelatin constructs were 91.2 ± 7.6 ms, 87.4 ±
9.2 ms, and 75.2 ± 10.3 ms respectively. At the end of the study T2 decreased to 67.9 ±
3.1 ms for the silk, 61.1 ± 3.8 ms for the gelatin, and 58.4 ± 4.2 ms for the collagen
constructs. Our data showed that T2 times dropped 25% for the silk, 30% for the gelatin,
and 22% for the collagen in the course of the study.

Figure 6-3 Collagen construct development map over an 8-week in vivo study at four
time points. Shown from left to right are the magnitude SEMS image, T2 relaxation
map, and stiffness map of the constructs. Average T2 relaxation times decreased
from 75.2 ±- 18.4 ms at week 2 after implantation to 61.3 ± 7.1 at week 4 ms and 58.4
± 4.2 at week 8. Average stiffness values increased from 4.6 ± 1.7 kPa at week 2 after
implantation to 12.0 ± 3.7 kPa at week 4 and to 14.7 ± 3.8 kPa at week 8.
Shear stiffness data for all three constructs are illustrated in Figure 6-4b. The gelatin
construct showed the most shear stiffness increase from 6.4 ± 1.0 kPa to 22.6 ± 4.1 kPa.
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Shear stiffness of the collagen construct increased moderately from 4.6 ± 1.7 kPa to 14.7
± 3.8 kPa from week 2 to week 8. Shear stiffness of the silk construct increased less than
the others from 7.6 ± 2.0 kPa to 17.2 ± 3.1 kPa.

(a)
(b)
Figure 6-4 Characterization of T2 relaxation time and shear stiffness as imaging
markers for three hMSC seeded cartilage constructs (silk, gelatin, and collagen). (a)
Comparison of the T2 relaxation alterations among the cartilage constructs. (b)
Comparison of shear stiffness changes among the three cartilage constructs.
Transcript levels of cartilage-related ECM genes were assessed using RT-PCR to
determine chondrogenic differentiation after 3 weeks of in vitro culture and 8 weeks of in
vivo implantation of MSCs seeded on silk, collagen, and gelatin scaffolds. Levels of Agg
and Collagen II, cartilage-related ECM genes, were analyzed and normalized to GAPDH
within the linear range of amplification. As shown in Figure 6-5, transcript levels of Agg
and Collagen II in cells within the gelatin (a) and collagen (b) constructs of in vivo
implantation were significantly upregulated in comparison to in vitro culture and the
control (P<0.001). The transcript levels of Collagen II in cells within the silk (c)
constructs of in vivo implantation were significantly upregulated in comparison to in vitro
culture and the control (P<0.001). The transcript levels of Agg in cells within the silk (c)
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constructs of in vivo implantation were upregulated in comparison to in vitro culture and
the control (P=0.076).

Figure 6-5 Transcript levels measured by RT-PCR for Aggrecan (Agg) and
Collagen type II (Collagen II) of cartilage-relate ECM genes in vitro and in vivo
within the gelatin (a), collagen (b) and silk (c) construct. Data are shown relative to
the expression of the respective transcript by undifferentiated MSCs at week 3 and
represented as the average ± standard deviation (***P<0.001).
6.4 Discussion
In this study, longitudinal evaluation of hMSCs-derived cartilage constructs,
seeded into three types of scaffolds (silk, collagen, and gelatin) and implanted
subcutaneously in mice, were performed by measuring transverse MR relaxation time T2
and shear stiffness. We have explored the potential of stiffness mapping as well as T2
mapping at 9.4 T in characterizing cartilage growth, a “tissue engineering” approach,
after implantations. Expression of Agg and type II Collagen genes was measured by
gene-specific quantitative competitive reverse transcriptase-polymerase chain reactions.
The in vitro culture is very important before implantation on the engineered
articular cartilage properties and alleviation of post-implantation inflammation in
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different animal models [275-277]. The current study cultured the tissue-engineered
cartilage within silk, collagen and gelatin scaffolds over 3 weeks. The expression of
cartilage related ECM genes were analyzed by RT-PCR. The current results confirmed
the expression of Collagen II and Agg were upregulated within silk, collagen, and gelatin
scaffold after 3 weeks in vitro culture, compared with control (Figure 6-5).
In cartilage tissue engineering several factors must be investigated after
implantation, such as localization, depth, and diameter of the constructs, the type of
scaffolds, cells, and growth factors. To date, macroscopic and histological studies remain
the “gold standard” to characterize the type and the quality of the repair tissue at different
time points, but are invasive in nature. For example arthroscopy, while promising, limits
the number of longitudinal explorations in clinical practice. Therefore, the development
of noninvasive techniques seems necessary for the future to evaluate longitudinally the
different tissue engineering techniques used for cartilage repair. Numerous studies have
been performed to study effective imaging markers in tissue repair in various
experimental models of cartilage defects in human [278-280] or animal [281, 282].
Chou1 et al. in a study temporally characterized the magnetic resonance relaxation time
of a tri-copolymer sponge in vivo in a rodent heterotopic model. They described that the
transverse MR relaxation time (T2) of the sponge decreased significantly over time while
longitudinal relaxation time T1 remained stable, compared with the control [283]. Ballyns
et al. used MRI and CT to design custom-printed molds that enabled the generation of
anatomically shaped cartilage constructs [284]. To our knowledge, previous studies of
cartilage growth characterization using both T2 values and shear stiffness have not been
performed.
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In the current research, we noted in all three types of implanted cartilage
constructs a progressive and significant decrease of T2 over the 8-week study. Average
transverse MR relaxation time decreased 25% for the silk, 30% for the gelatin, and 23%
for the collagen based constructs. Total differentiated tissue was characterized by the
smallest average T2 value comparing to the onset of the study. This reduction can be
because of a decrease in the relative water content and an increase of T2-shortening
effects in the constructs. We also observed stiffening of the tissue constructs along with
the differentiation and growth of the cells. MRE measurements revealed that the shear
stiffness increased nearly two-fold for the silk, three-fold for the collagen, and three-anda-half-fold for the gelatin based cartilage constructs. This increase in shear stiffness of the
constructs can be due to formation of their net-like organized structure of the collagen
type I and II fibers and increasing concentration of proteoglycans (PGs) [285]. In
agreement with previous reports [286-288], the current results demonstrated that the
expression of Collagen II and Agg were upregulated within silk, collagen, and gelatin
scaffold after 8 weeks implantation, compared with in vitro culture (Figure 6-5).
Cartilage is affected in vivo and in vitro by several biomechanical forces like
direct compression, tensile and shear forces, or the generation of hydrostatic pressure and
electric gradients, as well as changes in the pH [285]. The dynamic processes that occur
in cartilage are necessary to maintain its structure and function and have to be applied in
the tissue engineering of cartilage as well. These effects and their correlation with
imaging biomarkers can be investigated in future studies.
The results of this research demonstrated that MRI provides the basis for
morphological evaluation of engineered cartilage tissues, whereas biochemical MRI
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(measuring transverse MR relaxation) provides deeper insight into the composition of the
tissue. Besides, MRE allows observing changes in mechanical properties of the
engineered tissue. The imaging markers achieved in this study through noninvasive
biomedical imaging techniques can improve cartilage repair and also can be used for the
diagnosis of surrounding pathologies within defect sites. The method introduced in the
present study can effectively reduce the number of animals needed for statistical
significance in any further in vivo study without compromising reliability. A combination
of all of these together may, in the future, represent a desirable multimodal approach to
follow-up after cartilage repair procedures.
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CHAPTER 7
ASSESSMENT OF NONALCOHOLIC FATTY LIVER DISEASE USING MRE AND qPCR
7.1 Introduction
Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic hepatic
disorder among cases with acute obesity [289]. It can progress from primitive steatosis to
steatohepatitis and cirrhosis in patients without signiﬁcant alcohol use [80, 290]. NAFLD
is one of the diseases in vogue worldwide, especially in developed countries, with a
prevalence of 30% in adults and 13% in children [290-292]. A wide range of liver
diseases can be included in the NAFLD spectrum such as fatty liver or steatosis
(agglomeration of fat in hepatocytes), nonalcoholic steatohepatitis, NASH (inflammation
in liver due to fat) and cirrhosis (progressive and irreversible stage of fatty liver disease
leading to scarring in liver) [293]. In 2011, United Network for Organ Sharing registry
database for liver transplant recipients reported that NASH, the progressive form of
NAFLD, is the fourth most leading cause of liver transplant surgery [294]. Sedentary life
style, fast-food consumption, and the tendency of people to consume high-fat and highfructose corn syrup content food are significant factors which increase the number of
NAFLD in developed countries [295]. Studies showed that the mean body mass index
(BMI) and type 2 diabetes are important factors that increase the risk of NAFLD [296,
297].
Pathogenesis of NAFLD is defined as agglomeration of fat inside hepatocytes
leading to a metabolic disorder identified with central obesity and insulin resistance [291,
293]. Histologically, existence of steatosis of more than 5% is an evidence for NAFLD.
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In the progressive stage, steatosis advances to steatohepatitis, which is signaled by the
presence of steatosis inflammation and hepatocellular injury [294]. The frequent causes
of NAFLD are central adiposity, obesity, insulin resistance, metabolic syndrome and type
II diabetes [289]. Figure 7-1 demonstrates the relationships between different types of
NAFLD [78, 298] .

Figure 7-1 Interactions of different factors in pathogenesis of NAFLD. Life style,
genetic defects, diabetes, and hepatic C virus can result in insulin resistance which is
an important factor in developing NAFLD.
Among them, insulin resistance was shown to play a significant role in NAFLD [299].
Several biomarkers of insulin resistance have been investigated in previous studies such
as interleukin (IL)-6, tumor necrosis factor a (Tnfa), and leptin [300], insulin-like growth
factor-1 (Igf1) [62], aka Glut4 (insulin resistance is suppressed by increase of aka Glut4
expression) [301], and various antioxidant defense markers such as Sod1 and Sod2
(relative gene expression decreases following NAFLD) [302]. aka Tnfa plays a
significant role in insulin resistance by damaging insulin signaling; therefore, an
increased level of Tnfa in hepatocytes is an exacerbating factor in fatty liver disease
[298]. Other studies showed that nonalcoholic steatohepatitis is relevant to increased
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microsomal cytochrome P450 2E1 (CYP2E1) expression in liver cells by changing the
activity of mitogen-activated proteins [303]. The mRNA level changes of these genes in
NAFLD can be disruptive for cell proliferation, differentiation, apoptosis, or migration;
thus, quantification of their abundance and assessment of their correlation with shear
stiffness in NAFLD may be advantageous in the diagnosis and treatment stages. In
current research, real-time Polymerase Chain Reaction (PCR) is utilized to quantify and
monitor gene expression changes in the liver [304].
Imaging modalities such as ultrasound, computed tomography (CT), and magnetic
resonance imaging (MRI) are commonly employed in the diagnosis of NAFLD [305].
While imaging techniques are merely suggestive, the histological features of biopsy
samples taken from fatty liver are considered as a gold standard for determining the
severity of the disease [306, 307]. However, it was reported that liver tissue histology in
patients who have suffered from NAFLD in the cirrhosis stage do not necessarily show
enough features for this form of assessment [294]. Furthermore, promising assessment of
NAFLD is achieved by taking several biopsy samples at different time points for
monitoring the progression of NAFLD [296, 308]. For instance, Charlton et al. reported
that a number of biopsies in a year rather than yearly biopsies are necessary to detect the
high rate of steatosis [309]. Therefore, an analysis of more biopsy samples over time may
be required to monitor the degree of fatty liver disease which is unpleasant for patients
[294].
Knowing that MR imaging, the dominant soft-tissue imaging technique, is not
able to reliably assess the intermediate stages of fibrosis [310], magnetic resonance
elastography (MRE) has emerged to noninvasively measure the liver’s stiffness. MRE
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can correlate the presence of liver fibrosis in patients with chronic liver disease [254].
First described by Muthupillai et al. in 1995, MRE is a phase-contrast based MRI
technique that uses propagating shear waves through tissue to noninvasively characterize
mechanical properties of materials such as the shear modulus (μ)or Young’s modulus
[76]. Historically, physicians have been using palpation to discover unusual changes in
mechanical properties of tissues, which can be a sign of abnormalities such as cancers
and tumors; however, diagnosis through palpation is constrained to the approachable
areas of the body. On the other hand, CT, MRI, and ultrasound frequently fail to detect
stiffness alterations of tissues in a number of pathological conditions, for example, in
fibrotic liver diseases which are detectable by MRE [77-79]. Besides magnetic resonance
elastography, ultrasound based elastography (UE), introduced by Ophir et al. in 1991, is
another noninvasive method for imaging the elasticity of biological tissues. Although UE
is a successful method and is clinically used, it is limited by the signal to noise ratio
(SNR) and low resolution [76, 80, 81]. Recently, MRE has been demonstrated in clinical
studies as a diagnostic method for abnormalities in breast, liver, kidney, prostate, brain,
blood vessels, heart, and skeletal muscle. Additionally, MRE was approved clinically by
the food and drug administration (FDA) for assessment of chronic liver diseases [8-11].
The objective of this feasibility study was to evaluate the correlation of liver
stiffness alterations with changes of fibrosis-specific genes expression for assessment of
NAFLD. Microscopic MRE, described by Othman et al. in 2005 [82, 86, 311] as a
method of high spatial-resolution MRE, was used to quantify mechanical properties of
the liver tissue. Difference in liver tissue stiffness between normal mice and subjects
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suffering from NAFLD was measured. Real-time PCR was performed on the genes
playing an important role in NAFLD to quantitate their mRNA abundance.
7.2 Experimental
7.2.1 Animal Handling
All animal experiments approved by UNL’s Institutional Animal Care and Use
Committees (IACUC).Eleven C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) 7week old weighing 23-25 g were randomly grouped into control (n=5) and pathologic
(n=6) populations. The pathologic population was allowed to consume an unlimited
amount of a high fat diet (TD.06415 adjusted calorie diet [45/Fat]) during a four week
study while the control group was fed a regular rodent diet (2016 Teklad Global 16%
Protein). Animals were kept in metabolic cages under ordinary day-night cycles of light,
temperature, and pressure. Mice acclimated to the environment for a week before starting
the experiments. The normal group and the diseased group were imaged once a week in
the course of the exposure period. Before imaging, the mice were placed inside a closed
chamber and induced by 2% isoflurane, an inhalation anesthetic, using an anesthesia gas
veterinary evaporator (Molecular Imaging Products Company, Bend, OR). Then, they
were positioned in ventral recumbency onto an animal holder, shown in Figure 7-2, in
such a way that their snouts were inside a nose cone connected to the anesthesia
evaporator, thus allowing inhalation of anesthesia during the experiment (Figure 7-2).
The anesthesia was kept at 0.5-2% isoflurane in O2 with a flow rate of 2 ml/min
throughout the imaging study. The animal’s respiration, heart rate, and body temperature
were monitored throughout imaging by an MR-compatible small animals monitoring and
gating system (Small Animal Instruments, inc., Stony Brook, NY) [312]. This system is
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designed for small rodent imaging and can be linked to an MRI scanner for gating. A
rectal thermistor temperature probe covered with lubricant was mounted and its lead was
taped to the mouse’s tail. The animal’s respiration rate was measured by a pneumatic
sensor placed near the abdomen and secured with tape. Heart rate was monitored using a
mouse tail/ankle fiber optic oximetry sensor attached to animal’s left ankle. A loop of
thread was placed around the foot of the mouse and taped to maintain the ankle in the
sensor. An air heater was utilized to regulate the animal’s body temperature inside the
magnet bore.
7.2.2 MRE Setup
All MRE experiments were performed at 9.4T (400 MHz for protons) utilizing an
89 mm vertical bore MR scanner (Agilent, Santa Clara, CA). MRE acquisitions were
acquired using a 40 mm Millipede RF imaging probe with triple axis gradients
(maximum strength 100 G/cm).
Piezoelectric Bending Driver
MRI
Console

Triggering Pulse

Amplifier
Function
Generator

Motion Direction
Direction

Nose Cone

Figure 7-2 Schematic diagram of in vivo experimental setup for MRE assessment of
liver tissue. A piezoelectric actuator is coupled with the skin of the animal above the
liver and inclined to right lateral side of body. The specially designed cap transfers
545 Hz transversal vibration to liver tissue by oscillating the right lateral side of the
animal body. The resulting traveling shear waves propagate through liver tissue
from the posterior to the anterior.
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Propagating shear waves were generated through transverse motion of an
especially designed actuator shown in Figure 7-2. The actuator consisted of a bending
piezoelectric motor (Piezo systems, inc., Woburn, MA) attached to a plastic cap designed
to transfer the motion to the animal. It was secured to a curvature around the animal and,
by coupling it to the right lateral side of the animal above the liver, motion was
transferred to the liver tissue. The actuator was driven using an amplified sinusoidal
signal generated by a function generator (Tektronix, Beaverton, OR) and triggered by the
MRE imaging sequence through a triggering pulse from the MR scanner console. The
transverse motion generated shear waves propagating through liver tissue in a posterior to
anterior pathway. Prior to imaging, actuator characterization was carried out utilizing a
Laser Doppler Vibrometer (Polytec, Dexter, MI) to generate maximum tissue
displacement, approximately 50-150 µm. A laser beam was pointed onto the surface of
the plastic cap attached to the piezoelectric bending motor. The reflected beam was
applied by the vibrometer to measure actuator’s velocity and displacement. The
displacement amplitudes of the actuator were in the order of 200-400 µm. Typical
velocity and displacement signals of the actuator are shown in Figure 7-3.

Figure 7-3 Characterization of the actuator using a Laser Doppler Vibrometer.
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Studies showed that at least a half wavelength traveling through a tissue is
necessary to calculate its mechanical properties [313]. On the other hand, using higher
frequencies leads to more attenuation and less wave propagation within the tissue. To
reduce these effects on our measurements, frequencies ranging from 500 to 600 Hz were
used in this study, which were determined through preliminary experiments.
MRE acquisitions were conducted using a gradient-echo based phase contrast
sequence with repetition time TR of 300 ms, echo time TE of 4-5 ms, flip angle of 25º,
acquisition matrix of 128×128, axial field-of-view FOV of 24 to 28 mm2, average=2 and
slice thickness of 1 mm. The applied mechanical vibration was generated by a sinusoidal
signal with Vpp (peak-to-peak voltage) of 200 V and the resonance frequency of the
actuator. The number of gradient pulses and maximum of motion-encoding gradient were
selected to be one and 80-90 G/cm respectively. The motion-encoding gradient pairs are
incorporated along the same direction as the shear waves, at the same frequency of
mechanical excitation, and phase-locked to it. To compensate respiratory and cardiac
motion, MR acquisitions were gated using respiration and pulse oximetry trigger signals.
The total acquisition time was approximately 7:40 min. To calculate the local
displacement and shear moduli maps (elastograms), imaging was repeated in six phase
offsets equally distributed over one cycle of the mechanical excitations. Six offsets were
used instead of eight offsets to shorten the in vivo imaging time. The acquisitions were
performed twice, toggling the polarity of gradients for phase image subtraction and
generating wave images. The intensity of each pixel on wave images indicates
displacement amplitude at that point in the direction of applied motion-encoding
gradients. To avoid wrapping artifact we tried to adjust the maximum of motion-encoding
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gradient or the amplitude of displacement within the tissue; however, in some cases,
because of necessity of applying stronger displacements near actuator to achieve
sufficient penetration depth, phase-wrapping was unavoidable; these cases were phase
unwrapped by applying a two-dimensional Fourier Transform algorithm [314].
The mass density of tissue-like materials is close to that of water (1000- 1100
kg/m3); therefore, the shear modulus at f=545 Hz, at which most of experiments were
done, and ρ=1050 kg/m3 can be simplified to

. The wavelength of

traveling shear waves can be determined by measuring the peak-to-peak distance of the
wave train in the direction it is propagating. In this study, a MATLAB code written based
on a previously developed spatiotemporal filtering approach was utilized to solve the
inverse problem and calculate the local mechanical properties of the liver tissue from the
measured wave images [85-87, 315]. The complex pattern of traveling shear waves in
anisotropic and heterogeneous material can be handled using multi-directional filtering
[86]. In the applied algorithm, each wave field was filtered in 8 different angles
(multiples of 45º) and the weighted data from all directions were combined to reconstruct
the local mechanical properties [86, 297]. A region-of-interest (ROI) surrounding the
liver tissue was selected from the magnitude image. Any regions of ROI that didn’t have
enough shear wave amplitude (due to insufficient MR signal or weak penetration) were
excluded. Means and standard deviations (SD) of stiffness values were calculated over
the ROI for all mice in each study group. Eventually, the mean and SD of each study
group were determined in order to find the cross-subject alteration. SD of each study
group were calculated using the following equation
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∑

∑

(7.1)

where nj represents the number of pixels in each ROI, Mj and SDj are ROI mean and
standard deviation respectively, and M is the mean of all subjects.
7.2.3 Body Scan and Real-time PCR
At the conclusion of the four week study, the animals were euthanized and the
tissues were excised for the body scan. The densities of fat in the liver tissues were
measured using the Lunar PIXImus dual-energy x-ray absorptiometry (GE Medical
Systems-Lunar, Madison, WI). To quantify the mouse fibrosis-related genes, adipose,
muscle, and liver tissues were isolated and RNAs were collected for the qPCR analyses
using the 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA).
Forward and reverse primers were designed and synthesized for the mouse Tnfa,
Lep, Igf1, Slc2a4 (aka Glut4), Sod1 and Sod2 genes, as given in Table 7-1. Each set of
primers was tested empirically to determine the maximal concentration that produced
specific amplification of the target sequence. qPCR reactions were carried out using
equivalent dilutions of each cDNA sample, Power SYBR Green PCR Master Mix
(Applied Biosystems), and the empirically determined concentration of each primer as
previously described [316]. The relative abundance of each specific gene product was
divided by the relative abundance of β-actin in each sample to generate a normalized
abundance for each gene interrogated. The resulting normalized data for each candidate
mRNA was then compared to the mean normalized mRNA abundance in mice fed with a
normal rodent chow.
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Table 7-1 qPCR primer sequences for mouse Tnfa, Lep, Igf1, Slc2a4 (aka Glut4),
Sod1 and Sod2.

7.2.4 Statistical Analysis
The statistical analyses for MRE and qPCR data were performed using GraphPad
Prism 5.0 (GraphPad Software, La Jolla, CA). A paired student t-test was performed to
determine the significance of the liver stiffness variations as well as gene expression
alterations between normal and diseased populations.
7.3 Results
During the study, the body mass of animals increased from 24 ± 1 g to 27 ± 1 g in
both healthy and diseased groups. Figure 7-4 shows axial magnitude image from the liver
tissue of a typical healthy mouse and corresponding filtered shear wave image and
stiffness map. The shear wave image and shear stiffness map were generated inside a
ROI drawn to cover the largest region of the liver tissue possible to avoid the vascular
system. i.e., Axial MRI images of the liver tissues include transverse cross section of the
liver vasculature, which should be eliminated from ROIs selected for post-processing.
MRI magnitude and phase images were segmented through different available options,
including threshold, Fuzzy C- means [317], and manual. The average estimated shear
stiffness for the healthy liver tissue was about 4.7 ± 0.7 kPa acquired at 545 Hz. The
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imaging was repeated weekly (five times) during the study. Figure 7-5 illustrates
magnitude images, filtered shear wave images, and stiffness maps of the liver tissue
acquired for a mouse belonging to the diseased group at five time points. After three
weeks of study, the shear stiffness map demonstrated areas of higher shear modulus.

Figure 7-4 Demonstration of an axial magnitude image from the liver tissue of a
typical healthy mouse and corresponding filtered shear wave image and stiffness
map. The liver tissue is highlighted by a dashed line. A region of interest highlighted
by a white line chosen to include the liver tissue and avoid vasculature system of the
liver (Vasculature system should be excluded from calculations). The place of the
actuator and the direction of vibrations are denoted by a white dotted arrow.
Table 7-2 lists means and SDs of stiffness, storage and loss modulus measured for
healthy and diseased populations during the study. A comparison of shear stiffness
between these two populations is represented in Figure 7-6. The liver stiffness increased
within the fatty liver tissue. No region of such high stiffness has been measured in
corresponding control animals. The mean stiffness in fatty diet group changed from 4.3 ±
0.7 kPa to 7.2 ± 1.0 kPa (P<0.02) after four weeks of feeding with high fat diet.
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Magnitude Image Filtered Waves (μm) Stiffness (kPa)

Figure 7-5 Magnitude
images, filtered shear
wave, and stiffness
estimations of a mouse
liver at five different
time points. Imaging was
carried out using a
gradient echo based
imaging sequence with
the following
parameters: TR = 300
ms, TE = 4-5 ms, FOV =
24-28 mm, slice
thickness = 1 mm,
matrix = 128 x 128
pixels, NEX = 2,
operating frequency =
545, number of bipolar
pairs = 1, and gradient
amplitude = 80-90 G/cm.
An increase in stiffness
can be seen in the liver
tissue at the end of the
study, while values in the
healthy subjects change
insignificantly. The place
of the mechanical
actuator coupled to the
animal’s body is
illustrated by a dotted
line in all magnitude
images. The arrows
show the direction of
vibration.

After four weeks, body composition data showed a slight difference from 19.54 ±
1.65 to 17.28 ± 0.64 in body fat percent between mice fed a high fat versus control diet
respectively (P<0.3). Figure 7-7 shows the alterations in mRNA abundance of Slc2a4
(aka Glut4), Igf1, Sod1 and Sod2 in the liver and muscle of high fat group compared to
the control. Liver glut4 mRNA abundance was increased nearly 4-fold (P < 0.6) in liver
tissue while in the muscle tissue didn’t change significantly. Furthermore, leptin mRNA
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abundance was elevated approximately 2-fold (P < 0.1) in adipose tissue whilst Tnfα
decreased %10 in high fat diet group.
Table 7-2 The means and standard deviations of measured stiffness, storage
modulus, and loss modulus at five time points during the study for both normal and
high fat diet groups.

Figure 7-6 Mean and SD values of the liver stiffness for high fat group versus
control (P<0.02).
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Figure 7-7 mRNA abundance for fibrosis-related genes measured for the liver tissue
and muscle. (ND: Normal Diet, NFD: High Fat Diet).
7.4 Discussion
This research is the first to compare MRE liver stiffness and fibrosis-related gene
expression changes between mice with NAFLD and healthy populations and then study
the correlation between stiffness and gene expression. First the feasibility of the MRE to
quantitate nonalcoholic steatohepatitis was investigated. The feasibility was proven by
observing 40% increase (from 4.3 ± 0.7 kPa to 7.2 ± 1.0 kPa, P<0.02) in the mean
stiffness of the liver tissue for the diseased mice after feeding them with the high fat diet
food for four weeks. Furthermore, these results suggest a cutoff stiffness value 6.5 kPa
which can be utilized in a diagnostic procedure and surveillance of NAFLD. Previous
studies on liver fibrosis carried out on human and animal models presented different
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stiffness values corresponding to similar stages of liver fibrosis. Early change of liver
stiffness before appearance of liver fibrosis in animal models has been reported in
previous studies [318-320]. In a similar study, Salameh et al. reported that mean elasticity
of liver tissue increased nearly 23% (from 1.82 kPa ± 0.22 to 2.24 ± 0.19 kPa) in a wellestablished NAFLD rat model after the week 2 while fibrosis is significantly increased
after week 5. They reported the percentage of fibrosis increased from 1.4% ± 0.6 in the
control group to 3.7% ± 1.5 at 5 weeks while remained nearly constant at week 2 (1.5% ±
0.4). In another study, Yim et al. suggested a cutoff stiffness value of 1.61 kPa for
hepatic liver fibrosis where their control groups have a mean shear stiffness value of 1.38
± 0.20 kPa. Their results showed shear stiffness of fibrotic liver nearly increases 20% for
3-month-old mice and 55% for 12-month-old. The type of actuator, lower vibration
frequency (120 Hz), the extension of fibrosis, specimen type, and age, can be reasons of
different measured values comparing to our study. In our study, the stiffness values of
normal group also increased slightly in the course of the study which can be due to effect
of age on liver tissue [320]. However, the significant alteration of the stiffness values in
diseased cases, prior to the point that it is detectable by histology, confirms the reliability
of noninvasive MRE scan compared with random liver biopsy. Several factors have been
reported that are involved concurrently or in sequence in early increase of stiffness prior
to myofibroblast activation (liver fibrosis is detectable after this point). Fibrogenesis
markers like myofibroblast activation build up matrix stiffness and tightness [318, 319,
321-323]. Other factors which can be found in literatures are inflammation [324], portal
hypertension [325], and collagen cross-linking by members of the lysyl oxidase protein
family [318].
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In addition, the results of our study showed the capability of MRE to evaluate and
follow liver mRNA abundance of Glut4 and Igf1, as determined by real-time PCR
analysis. mRNA abundance of Glut4 demonstrated a significant increase for high fat diet
group at the end of the study. A slight increase in Igf1 mRNA was also observed.
However, Tnfa, Sod1 and Sod2 mRNA expression didn’t change significantly between
two populations.
The gradient-echo and spin-echo based MRE sequences were developed and
tested to obtain high quality and high SNR sufficient for post-processing algorithms.
Since shorter echo time is inevitable to acquire higher MR signal in the liver tissue,
gradient-echo based sequence which allows relatively shorter echo time worked better
than spin-echo based sequence but still more SNR was required. This problem was solved
by applying both cardiac and respiratory gating. Without the cardiac gating, a high
quality and artifact-free GEMS image of the liver was not possible. In this study, in order
to improve the functionality of applied gating system, the animal’s respiratory rate was
maintained around 50 breaths per minute. This study was limited by the small number of
specimens. Obviously, more animals are necessary to better correlate shear stiffness and
gene expression with the different NAFLD stages. The designed actuator utilized a
bending piezoelectric motor to generate transverse vibration. Further developments,
especially using a stack actuator, are expected to create stronger motions that are
adjustable to the patient's anatomy.
7.5 Conclusion
This study confirmed that MRE is able to noninvasively observe changes in the
mechanical properties of the liver tissue such as stiffness and following that diagnose the
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nonalcoholic fatty liver disease. Besides the liver stiffness, relative gene expression of
Glut4, a fibrosis-specific marker, increased 4-fold at week 4. Knowing that no signs of
obesity or fat were observed in both groups, the results of this research indicate that the
expression of Glut4 and the noninvasively measured liver stiffness can both be used as
reliable biomarkers for early detection of liver fibrosis in NAFLD subjects. This may
suggest that the increase in liver stiffness is associated with increased expression of Glut4
in NAFLD subjects; however, more investigation is recommended as a future direction
using a larger number of animals. Later studies can be designed to correlate multiple MRbased tools such as diffusion-weighted MRI, T1 and T2 relaxation maps, and MRE with
the variations in liver gene expression for liver fibrosis detection. Moreover, attenuation
of fibrosis in NAFLD treatment and its effects on gene expression and MRI-base data can
be investigated.
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CHAPTER 8
SUMMARY AND OUTLOOK
This dissertation is concerned with studying various applications of novel MRI
technologies in tissue engineering and disease diagnosis, including the development of an
MR-compatible incubation device capable of simultaneous culturing and imaging of cell
growth under an autonomous in vitro stable controllable environment; the observation of
bone tissue repair in a critical-sized calvarial defect model using MRI and near infrared
optical imaging; characterization of imaging biomarkers for various tissue engineered
cartilage constructs using MRI and MRE; and evaluation of the correlation between the
liver stiffness and the liver genes expressions in nonalcoholic liver disease.
8.1 The e-incubator system
The aim of this study was to evaluate the design of a novel small-scale, portable,
autonomous system, known as the e-incubator, which would enable real-time
visualization of cultured tissue constructs or biological compounds in miniature sizes for
different geometries and in a closed controlled environment. The design follows the need
for a system with real-time tomographic imaging capability, which is enabled by
integrating the platform with a high-field MRI system. All applied parts were designed
and adapted to facilitate MRI imaging and to reduce MR signal loss.
The e-incubator design provides a sterile environment, control over culture
conditions (such as temperature, CO2 level, nutrient supply, waste drain, and growth
factors), transparency to MR signal, accessibility of the culture for imaging, and
media/gas reservoirs. Additionally, its chambers (including necessary components)
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should be nonmagnetic and compact enough to readily fit inside the relatively narrow
bore of most MRI micro-imaging systems; it should place the culture in the center of the
field-of-view (FOV) while other parts can be outside of the scanner; it must be easily
inserted in and out of the MR scanner. The e-incubator system can be easily tailored to
any imaging system and can support multiple culture chambers, which allows for the
culturing of several constructs. Prior to studies, culture conditions, growth factors,
imaging schedule, harvesting time and implantation should all be planned. In a
preliminary investigation various materials, electronics, sensors, mechanics, connections,
biological materials and associated strategies are under examination to complete the final
design. Mesenchymal stem cells seeded into a gelatin scaffold sponge are exploited to
create a construct to produce bone. Through this examination we demonstrate the
functionality of the system, maintenance of sterility, imaging access and MR
characterization capability for the osteogenic construct within a four-week study. By
continuous imaging of the culture with the MRI system, we will quantify its NMR
parameters as the biomarkers for bone and will investigate the 3D structure of the
construct during its growth. The purpose of this paper is to describe for the first time the
design of the e-incubator system and demonstrate its functionality in a four-week
osteogenic construct culture study. While the e-incubator system was used to engineer a
bone tissue construct, it has the potential to be applied for versatile applications,
particularly cancer treatment.
The e-incubator was designed as a novel autonomous incubation system for longterm cultures, enabling us to appropriately track the culture using medical imaging
systems, here the magnetic resonance imaging. The obtained MRI images and
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corresponding data represent the capability of the system to work as an in vivo mimicking
environment that is observable in real-time by the imaging system. The viability test and
bone formation approved by histology verified that the e-incubator can be efficiently used
to produce human tissue-engineered bone. It also allows us to noninvasively measure the
MR properties of the construct and finally harvest it without exposing it to contamination
or any source of stress. This system has versatile potential applications in studies that
need an environment that closely mimics required in vivo conditions, such as regenerative
medicine, drug delivery, and pathophysiology of the diseases, in particular, cancer
treatment.
The CO2/Air mixing system designed for this platform employs two mass flow
controllers and a CO2 sensor. The sensor is employed to monitor and record the CO2
concentration for calibration and alarming purposes. However, a feedback loop in the
software of the gas/mixing system is missing and the current setup needs calibration
based on the length of tubing and the capacity of the gas reservoir. Therefore, a feedbackloop is required in order to remove the calibration phase and also to achieve more stable
CO2 concentration.
As the next step, we will transform the e-incubator into an MRI imagingcompatible bioreactor by applying mechanical and electrical stimulations to the cultured
construct which have been shown to deliver significant influences on the culture [326,
327]. Furthermore, nesting mechanical actuators around the culture chamber will permit
us to run the magnetic resonance elastography (MRE) experiments in order to measure
the mechanical properties of the culture during growth [33, 311, 328]. These
modifications might distort the homogeneity of the static magnetic field to such a degree
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that an additional correction will be necessary through a modified pulse sequence [329,
330]. Additionally, using a multiple-well sample holder, the e-incubator can be applied to
study tumors by incubating tumor cells in one chamber and the target tissue in the other
chamber. Moreover, contrast agents such as magnetic nanoparticles (iron oxide particles)
can be used to improve the contrast in the MRI image [331]. By labeling the stem cells
with these contrast agents, tracking the cells and their metabolism with MRI will be
feasible for the system. It is shown that loading stem cells with iron oxide leads to 70
times greater T2* sensitivity than for the T2-weighted images [332]. We combined the
incubation system with the high field MRI system; however, it has the potential to be
integrated with CT and PET imaging modalities, which can be studied in future projects.
8.2 Monitoring bone repair in a mouse calvarial defect model using multimodal
imaging
The aim of this chapter was to determine the feasibility of multi-modal imaging
techniques for observation of bone repair in a critical-sized calvarial defect mouse model.
Five nude mice were subjected to two 5 mm calvarial critical non-healing defects. One
site received an osteogenic silk construct after two weeks of in vitro culture and the other
received a plain silk scaffold with no cells as control. After removal of sutures, the
constructs were imaged using MRI and NIR optical imaging for monitoring the
regeneration of tissue engineered osteogenic constructs. All MR images were gated to
minimize blurring. Histological endpoint measurements and computed tomography (CT)
were used to confirm imaging findings. Anatomical MRI revealed decreased signal
intensity, indicating mineralization, in the TEB compared to the control, which is a plain
silk scaffold with no cells, at various growth stages. Based on this study, MRI can
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visualize mineralization but cannot differentiate ossified from calcified tissues. NIR
optical imaging results demonstrated that the osteogenic construct exhibited an increased
green fluorescence at month two compared to month one, while the control exhibited
little to no fluorescence. This result confirms the specificity of NIR to mineralization in
tissue-engineered bone. Taken together, these results demonstrate the potential of multimodal imaging to visualize and quantify tissue-engineered bone, which implies
noninvasive techniques for assessment of regenerative medicine strategies.
To improve results obtained from this feasibility study, it is necessary to verify
and enhance the quality of TEB implanted into the defect model. Use of a spinner flask or
a bioreactor for the pre-implantation culture can increase the quality of the tissue.
Additionally, in order to provide an even distribution of hMSCs, improved seeding
methods can be used for the silk scaffold dimensions rather than sectioning and
implanting it immediately prior to surgery. Furthermore, it may be necessary to verify the
quality of the TEB prior to surgery. Based on this study, fiduciary markers should be
used to register images acquired via different modalities, and more comprehensive TEB
evolution can be recorded. The same fiduciary markers can be used for the imaging
modalities to help with replication of animal positioning as the animals grow.
Future recommendations for this work also include characterizing the shear
stiffness of the TEB using MRE during its growth. A mechanical actuator can be
designed to generate mechanical waves propagating through the tissue constructs. The
stiffness of the tissue-engineered bone can be quantitated and used as an early
regeneration marker.
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Also, images acquired via different modalities would be fused to provide
comprehensive information on the development of engineered constructs. The aim of
image fusion algorithms is to integrate complementary information from a multi-modal
data set such that the fused images are more suitable for human and machine perception
or further processing [333]. An approach based on intelligent algorithms such as fuzzy,
neural network, wavelet, and genetic can be designed for multimodal medical image
fusion. The resulting image would improve human visual perception and computerprocessing capabilities to achieve more comprehensive information of the engineered
tissues in regenerative medicine.
8.3 MRI-guided evaluation of cartilage tissue engineering in vivo
In this chapter of this dissertation, work aimed to investigate the use of MRI and
MRE for characterizing the growth of tissue-engineered cartilage in vivo. There is a great
need for the development of a noninvasive method for observation of the composition,
structure, and function of the tissue-engineered cartilage at different growth stages. MRI
technologies possess a great potential to play a major role in evaluating tissue-engineered
cartilage due to providing tomographic, high resolution images noninvasively and with
various contrast mechanisms. Magnetic resonance elastography, a phase contrast MRI
technique, measures shear stiffness of tissues with the use of mechanical vibrations,
producing an acoustic wave which travels through the tissue. In this research, three types
of scaffolds including silk, gelatin and collagen seeded by hMSCs were implanted
subcutaneously in mice. The mice were imaged at 9.4 T using MRI and MRE to derive
biological (transverse relaxation time T2) and mechanical (shear stiffness) during an
eight-week in vivo study. At the end of the study, cartilage tissues were excised and

124
mRNA abundances of cartilage-specific genes were quantitated using the real-time
polymerase chain reaction (qPCR). Altogether, the outcome of this research provides
noninvasive, MRI-derived biomarkers for monitoring cartilage tissue growth after
implantation and enables design of better engineered cartilage that can be translated into
treatment of tissue defects.
The biomarkers characterized in the current research will play a leading role in
engineering cartilage and cartilage repair. Future recommendations for this work include
fusing MRI magnitude images, stiffness maps, and transverse relaxation maps to give a
comprehensive insight into the growth of cartilage. Also, the in vitro growth of the
cartilage constructs cultured into the e-incubator system can be characterized using MRI
and MRE. Then the constructs will be implanted in mice at multiple time points. The
quality of resulting cartilage tissue will be monitored during their growth and compared
with the biomarkers quantitated in this study. This will provide an optimal time for
implanting the tissue construct after initial incubating.
8.4 Assessment of nonalcoholic fatty liver disease using MRE and qPCR
The aims of this study were first to develop quantitative biomarkers for diagnosis
of nonalcoholic fatty liver disease as a potential alternative to biopsy using MRE and
qPCR and then investigate the correlation between these biomarkers. Local stiffness
alteration in tissues has been used by physicians to diagnose diseases through palpation.
Over the last decade magnetic resonance elastography (MRE), a novel imaging modality,
has been confirmed as a noninvasive, quantitative method for assessment of diseases
through measuring the stiffness of body tissues. In this dissertation work, correlation of
liver stiffness and fibrosis-specific genes expression in the evaluation of nonalcoholic
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fatty liver disease was assessed. Two populations of mice, including one fed with a high
fat diet and a control, were under study for four weeks. MRE measurements were
performed at 9.4 T to map the liver tissue stiffness. The changes of liver genes expression
between the two groups were also assessed at week four by transcription of mRNA
followed by real time polymerase chain reaction. Physiologically, this suggests a rapid
response of the liver to exposure to a high fat diet that may allow us to link liver tissue
stiffness and the changes in the fibrosis-specific genes expression in the liver to better
diagnose nonalcoholic fatty liver disease prior to the clinical onset of obesity. These
validations and analyses are important steps in the continued development and translation
of effective biomarkers of nonalcoholic fatty liver disease into clinical trials and as such,
the correlation can assist in early detection and quantitative staging of NAFLD.
Future studies should be conducted to identify the potential role of fibrosis-related
genes in a larger population of animals for better statistics. Later studies can be designed
to correlate multiple MR-based markers such as diffusion-weighted MRI, longitudinal
relaxation T1 and transvers relaxation T2 and shear stiffness with the variations of liver
gene expression for liver fibrosis detection. Moreover, attenuation of fibrosis in NAFLD
treatment and its effects on gene expression and MRI-base data can be investigated.
This study was to investigate early detection of NAFLD; therefore, it was
conducted in four weeks. Future research could focus on longitudinal variations of liver
stiffness measured for healthy liver, steatosis, steatohepatitis, and cirrhosis. Therefore,
the association of liver stiffness and changes in the liver gene expression at the different
levels of liver fibrosis can be investigated.
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Also, MRI can be used in quantifying NAFLD in severe stages, and the results
can be linked with liver stiffness and gene expression. The severity of steatosis can be
assessed by MRI through chemical shift imaging. Studies showed that MRI is superior to
other techniques such as ultrasound in detecting and quantifying minor degrees of fat
accumulation in the liver [334].
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